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General Introduction 
In the production of a large number of pharmaceuticals, continuous quality assurance 
has become a major issue. In 2004, the US Food and Drug Administration (FDA) 
proposed the Process Analytical Technology (PAT) with the aim of improving the 
development efficiency, quality, and productivity of pharmaceutical products.1 With 
this proposal, the introduction of systems/analyzers has advanced in the pharmaceutical 
manufacturing line. Figure 1 shows the conceptual diagram of PAT. In the PAT for 
pharmaceutical product manufacturing, clarifying the variable factors for the analysis 
and quality control of the manufacturing process, understanding the primary factors, and 
process improvement by feeding back the obtained results to the manufacturing process, 
are desired. For this purpose, an analyzer capable of real-time measurement is 
required.1-5 Further, for providing high quality pharmaceutical products in a stable and 
efficient manner, the concept of QbD (Quality by Design) has attracted attention. In the 
“Pharmaceutical development guidelines Q8” (R2) presented by the International 
Conference on Harmonization of Technical requirement (ICH), QbD is defined as a 
systematic approach to development that begins with predefined objectives and 
emphasizes product and process understanding and process control, based on sound 
science and quality risk management. Based on these guidelines, introduction of 
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analyzers into the process lines is actively being studied.6-7 
The in-line analysis tool is an essential technique to understand the formulation 
process and forms the core of PAT for implementing a new quality control system for 
pharmaceutical products. Since the in-line analysis tools can rapidly analyze without 
any impact on the manufacturing process, they have the advantage of obtaining a lot of 
high quality information for understanding the manufacturing process.1-3 
Spectroscopic techniques are one of the most effective methods of PAT in 
pharmaceutical processes.2,4,8,9 Representative spectroscopic techniques for industrial 
process analysis are an ultraviolet-visible (UV-Vis) spectroscopy, mid-Infrared (mid-IR) 
spectroscopy, Raman spectroscopy and Near-Infrared (NIR) spectroscopy.2 UV-Vis 
spectroscopy is effective for extracting qualitative and quantitative information 
regarding the contents of tablets.10 Mid-IR spectroscopy, NIR spectroscopy and Raman 
spectroscopy are effective for API concentration analysis, detection of intramolecular 
and intermolecular interactions, and evaluation of physical and chemical characteristics. 
It is also effective for evaluation of pharmaceutical blends and granulation 
processes.11-13 In particular, NIR spectroscopic analysis technology is promising as an 
in-line analysis tool and many studies and practical implementation are progressing. 
Because of NIR spectroscopy enables non-destructive, non-contact and rapid analysis 
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by a diffuse reflection method of pharmaceutical formulation. This feature is difficult to 
achieve with other spectroscopy. In addition, with the purpose of evaluating and 
analyzing the variations in component concentration distribution and non-uniformity of 
the final product or the target of the process, the developments in imaging devices are 
progressing.8,9 In particular, the NIR imaging device has become an important tool for 
understanding the quality characteristics defined in the QbD approach.14-17 
NIR spectroscopy is one of the analytical methods capable of rapid analysis using 
light in the wavelength range of 800 to 2500 nm. There are four main characteristics of 
NIR spectroscopy. First is to be able to observe the absorption spectrum derived from 
the fundamental vibration overtones and combination modes of the molecular vibrations 
of the functional groups (O-H, C-H, N-H) that contain hydrogen atoms. In addition, on 
the short wavelength region of NIR, absorption spectrum of electronic transition of 
molecules is observed. Second is to be able to analyze without choosing the state of the 
sample, namely solid, liquid or gas. The third is to be able to perform non-destructive 
analysis without requiring pretreatment of the sample. In particular, the state of the 
pharmaceutical sample is often the state of the powder. Therefore, NIR spectroscopy 
can be analyzed by using diffuse reflection method, which is advantageous for 
non-destructive measurement of powder. The diffuse reflection method is one of 
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reflection methods. The diffuse reflection method is a method of measuring reflected 
light that has been absorbed by repeating reflection, refraction transmission, scattering, 
etc. of NIR light inside the sample and then again outside the sample. The fourth is to be 
able to perform contactless remote analysis using glass or optical fibers.8,18 
Some of the representative spectroscopic methods of the NIR spectroscopic device 
are the Fourier transformation (FT) method, monochromator method, laser scan method, 
polychromator method and so on. Table 1 shows the features of each spectroscopic 
method. In the FT method, the spectrum is measured by Fourier transform of the optical 
interference signal obtained by moving in parallel a reflecting element such as a mirror 
and continuously changing the optical path length with the reference light.19 By 
providing a wavelength reference mechanism inside the spectroscopic device, long 
wavelength measurement accuracy can be achieved. Further, in principle, it has the 
superiority of optical throughput. However, since it has a movable mechanism of the 
optical element, there are a few demerits such as long measurement time and 
susceptibility to vibrations, but in recent years, it is widely being used in the field of 
spectroscopic analysis. In the monochromator method, spectra are obtained by filtering 
specific wavelengths using diffraction gratings or acousto-optic elements.20 In the 
monochromator method, wavelength scanning is performed by changing the angle of 
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the diffraction grating or the ultrasonic frequency of the acousto-optic device. Due to 
the high filtering effect of diffraction grating, high dynamic range and high wavelength 
resolution can be achieved. However, since specific wavelengths are cut out and 
measured, there are demerits such as long measuring time, large size, and susceptibility 
to vibrations. Laser scanning type (wavelength scanning type) is a method in which the 
light intensity from the sample is measured while scanning the wavelength of the 
irradiating light.21 Since laser light is used, high wavelength resolution and high 
dynamic range characteristics can be easily obtained. On the other hand, since the 
measurement wavelength range is limited by the oscillation range of the laser, it is 
expensive, as it needs many laser light sources for measuring a wide-band. In 
polychromator method, wavelength dispersion of NIR light is carried out using 
diffraction grating or the like and the spectral region is simultaneously detected by a 
multi-channel detector. Since polychromator method has high light utilization efficiency 
and it can be configured without mechanically movable parts, it has features such as 
high resistance to vibration and easy miniaturization.21 However, it is not as easy for the 
number of channels in the detector to increase the wavelength resolution compared to 
the other methods in order to determine the wavelength resolution.21,22 
Since the in-line analysis of the formulation process is often in bulk such as powder, 
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the spectroscopic method should be capable of detecting diffuse reflected light. Further, 
since the manufacturing process must be monitored in real time, functions such as high 
speed, compactness, and maintainability are required.2 From this point of view, if in-line 
NIR spectrometer take into consideration the contents of the features in Table 1, the 
polychromator type that has no mechanical driving part, can be considered suitable.2,21 
However, as described above, polychromator type spectroscopic device has the problem 
of low wavelength resolution.  
 
In this paper, in order to realize a high-sensitivity Photo Diode Array (PDA), it was 
developed a world-class high-density 640-element PDA detector and a charge amplifier 
Integrated Circuit (IC). Using the PDA sensor that combines the high-density PDA and 
high-sensitivity IC, a polychromator type NIR spectrometer was developed that has 
high-speed and high wavelength resolution characteristics.23 Since this 
polychromator-type NIR spectrometer possesses a high speed that can acquire a weak 
diffuse reflection spectrum in 10 msec or less, and a high wavelength resolution of 1.25 
nm or less, it can achieve all the functions of an in-line analysis tool. Figure 2 shows the 
developed in-line NIR spectrometer. Figure 2 (a) shows the fiber interface type NIR 
spectrometer, Figure 2 (b) shows the diffuse reflectance optical fiber probe, and Figure 
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2 (c) shows the spectro-engine of polychromator type NIR spectrometer. The fiber 
interface type NIR spectrometer is used with the diffuse reflectance optical fiber probe. 
Further, by combining the polychromator type NIR spectrometer and the mirror 
scanning optical system, a portable NIR imaging device was developed that can be used 
onsite. Figure 3 shows the developed portable NIR imaging device and the in-line NIR 
spectrometer. The portable NIR imaging device is used by connecting the in-line NIR 
spectrometer with optical fiber. The conventional NIR imaging devices are a 
microscope-type FT-NIR imaging device with motorized XY stage.14 Although the 
conventional NIR imaging device based on FT-NIR is excellent sensitivity and 
wavelength resolution, it has a problem of large size and slow measurement speed. 
However, the developed portable NIR imaging device is 18 cm × 20 cm × 22 cm in size, 
approximately 2 kg in weight and small enough to carry with one hand.24-26 In addition, 
the portable NIR imaging device can acquire NIR imaging data composed of 10000 
NIR spectra in approximately 15 minutes and has high speed of tenth times or more 
compared with the conventional FT-NIR type NIR imaging devices. Figure 4 shows the 
diagram of the function necessary for NIR imaging devices. Our portable NIR imaging 
device succeeded in offering the totally new function of portability to NIR imaging 
device. Using this in-line NIR spectrometer and NIR imaging device, the in-line 
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monitoring of the pharmaceutical product manufacturing process, tablet penetration 
analysis, and homogeneity of mixed samples and tablets were investigated.23-28 
 
In Chapter 1, in order to realize a compact, high resolution, high sensitivity, high 
speed polychromator type NIR spectrometer (P-NIRs), the world-class high-density and 
high-sensitivity array detector was developed.23 As P-NIRs use the newly developed 
640-element PDA detector, they show an improved wavelength resolution and high 
sensitivity. Since the existing NIR spectrometers have PDA detectors having up to 512 
elements, their maximum wavelength resolution is 1.56 nm. However, the newly 
developed PDA detector has made it possible to reach a wavelength resolution of 1.25 
nm or less. Further, by using the PDA detector in conjunction with the newly developed 
charge amplifier array, measurement time has been shortened to about one 100th (from 
1 sec to less than 10 msec). A high-performance prototype model was developed 
through mechanical investigation and prototyping of the remote DR detection 
mechanism necessary for the in-line monitoring of pharmaceutical processes, 
introduction of high-speed data processing, and addition of functions such as wireless 
interfaces. And a high-speed NIR spectrometer was developed for in-line use and 
validated its performance. In PAT, since the timely quality parameters and functional 
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properties of pharmaceutical products have to be monitored during the manufacturing 
process, high-speed P-NIRs are the extremely suitable NIR spectroscopes. Furthermore, 
due to its small size, it can be very easily installed in various pharmaceutical process 
lines. By measuring the DR-NIR spectra of D-mannitol and talc powders, P-NIRs were 
confirmed the achievement of high speed, high sensitivity, and high resolution. Further, 
P-NIRs was succeeded in the in-line monitoring of the mixed state of the powder 
samples using P-NIRs. 
 
In Chapter 2, the feasibility of analysis of API inside the bi-layer tablets was 
investigated on the millisecond timescale using NIR spectroscopy.27 In this experiment, 
the newly developed P-NIRs that can enable rapid spectral measurement of tablets were 
used. In the transmission measurement of tablets, since the transmitted light is 
extremely weak, measurement is difficult. However, since the NIR spectra of bi-layer 
tablets gave DR- and Tr-NIR spectra at 500 and 400 msec respectively. Comparison of 
the NIR spectrum with its second derivative showed that NIR spectrum was specific and 
selective with respect to the variations in ascorbic acid (AsA) concentration. 
Verification results and regression vectors demonstrated that the PLSR model enables 
the estimation of AsA concentration in bi-layer tablets. It was confirmed that the Tr-NIR 
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method was quite robust with respect to the orientation of the tablet. Therefore, this 
study is one-step towards the realization of real-time release test as it enables the 
transmission measurement of bi-layer tablets in less than a second.  
 
In Chapter 3, the application of new portable NIR imaging device (D-NIR) in the 
dissolution process of tablets for the needs of PAT and/or QbD is reported.25 In the 
conventional NIR imaging devices, since the NIR imaging is acquired while operating 
the sample, there are limitations on the speed and device size in acquiring the solubility 
of the tablet. However, since D-NIRs have high speed as well as portability, they are 
suitable for visualizing the dissolution process of the tablets that change moment by 
moment. The NIR spectra were measured in the 1000 to 1600 nm region of the model 
sample tablet containing 20 wt% of AsA and 80 wt% of HPMC as API during the 
dissolution process for up to 300 minutes. In the second derivative spectrum of the 
sample tablet, the 1361 nm band could be clearly identified as the unique band of AsA. 
As expected, the color contrast in the tablet dissolution image had changed before the 
start and this result was significantly enhanced by using the peak height ratio based 
images. The understanding of the tablet dissolution process, such as the degree of 
penetration of water into the tablet, can be improved by NIR imaging. The results 
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obtained in this study demonstrate that NIR imaging that uses the spectral variations 
such as band intensity variation and peak-height ratio variation at 1361 nm is a powerful 
tool for the evaluation of the tablet dissolution process.  
 
In Chapter 4, a new version of the NIR imaging device shown in Chapter 3 was 
developed.26 The new version achieved a high signal-to-noise ratio and high speed. The 
SNR of the new version is 10 times that of the old version and the measurement speed 
of the new version has improved to 7 times the old version. By using the new version, 
the blending monitoring was performed the in-line evaluation of the heterogeneity 
during the blending process and succeeded in determining the endpoint of homogeneous 
mixing. To evaluate the uniformity of mixed samples using the NIR imaging device, 
offline analysis at the laboratory was common. However, with the new version of NIR 
imaging device, it has become possible to perform at-line analysis at the site of the 
mixing process. In this experiment, using an in-line NIR spectrometer, continuous 
monitoring of the mixing process and NIR imaging spectra of the mixed samples were 
measured at different times. NIR imaging revealed that the AsA distribution in the 
blended sample varies over time. It was confirmed that a mixing time of 8 minutes was 
sufficient for homogeneous mixing. This study demonstrated that NIR imaging is 
12 
 
extremely useful for the further understanding of the results of in-line monitoring of the 
blending process.  
 
In Chapter 5, in order to facilitate the development of probe design and in-line type 
NIR spectrometer, an optical fiber switching system was developed that can switch 
between spot size variable type DR probe and NIR imaging device (D-NIRs).28 As an 
in-line analytical tool, the optimal design of a diffuse reflective probe is important in 
determining the spectral quality. However, the diffuse reflective probes are not designed 
considering the in-plane variations of powder samples. This switching system can 
acquire DR spectrum and NIR imaging data with one polychromator type NIR 
spectrometer (P-NIRs). Therefore, it was possible to evaluate the dispersibility and 
uniformity of the sample by NIR imaging and the quality of the spectral data obtained 
by DR probe. A model tablet containing 0 to 10% AsA was prepared as API and NIR 
spectrum in the 950 to 1700 nm region was measured using P-NIRs. The optical 
switching system provided with D-NIRs and P-NIRs was able to collect the DR 
spectrum and NIR imaging data rapidly, accurately, and automatically using the optical 
fiber-type switching module of the rotary mechanical parts. The NIR spectra of the 
model tablet samples were measured using spot sizes for the DR probe of ⌀1 and ⌀5 
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mm. The predicted concentration value of AsA was more accurate for ⌀5 mm than ⌀1 
mm. In addition, the optimal spot size using NIR imaging data was estimated to be ⌀5 
mm to ⌀7 mm. Therefore, the possibility of selecting a more suitable optical fiber probe 
by using a system that can switch between single point measurement type optical fiber 
probe and NIR imaging measurement is suggested.  
In this paper, developed a high speed, highly sensitive in-line NIR spectrometer and 
portable NIR imaging device were clarified that the visualization of pharmaceutical 
manufacturing process can be realized. These results suggest that the in-line NIR 
spectrometer and NIR imaging device developed for the quality control of 
pharmaceutical manufacturing process are useful analysis tools. The developed in-line 
NIR spectrometer and NIR imaging device are expected to be applied to chemical 
processes, paper production processes, film production processes, food production 
processes, agriculture, and healthcare in addition to pharmaceutical manufacturing 
processes. Furthermore, the developed high-density, high-sensitivity PDA detector can 
be expected to be applied to other spectroscopic methods (for example, application to 
Raman spectroscopy apparatus). 
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Figure 1 Diagram of conventional and PAT approach manufacturing process 
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Table 1 Table of the features of each spectroscopic method 
Fourier-
transform
Poly-
chromator
Mono-
chromator AOTF
Laser-
scan
Scan speed △ ◎ △ 〇 ◎
Spectral range ◎ 〇 ◎ 〇 ×
Spectral accuracy ◎ 〇 〇 〇 〇
Spectral resolution ◎ △(〇) ◎ △ ◎◎
Signal dynamic-range 〇～△ 〇 ◎ 〇～△ ◎
Device dimension 〇～△ ◎ △ 〇 ◎
Optical efficiency ◎ ◎ △ × ◎
Robustness △ ◎ △ ◎ ◎
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Figure 2 (a) In-line type NIR spectrometer, (b) diffuse reflectance optical fiber probe 
and (c) spectro-engine of P-NIRs 
(a) 
(b) 
(c) 
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Figure 3 Portable NIR imaging device and in-line NIR spectrometer: (a) in-line type 
NIR spectrometer, (b) portable NIR imaging device, (c) control box for NIR 
imaging device and (d) sample stage 
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Figure 4 The diagram of the function necessary to NIR imaging devices 
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Chapter 1 
 
A Polychromator-Type Near-Infrared 
Spectrometer with a High-Sensitivity and 
High-Resolution Photodiode Array Detector for 
Pharmaceutical Process Monitoring on the 
Millisecond Time Scale 
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Abstract 
In the fine chemicals industry, particularly in the pharmaceutical industry, advanced 
sensing technologies have recently begun being incorporated into the process line in 
order to improve safety and quality in accordance with PAT. For estimating the quality of 
powders without preparation during drug formulation, near-infrared (NIR) spectroscopy 
has been considered the most promising sensing approach. In this study, a compact 
polychromator-type NIR spectrometer equipped with a photodiode (PD) array detector 
was developed. This detector is consisting of 640 InGaAs-PD elements with 20 µm 
pitch. Some high-specification spectrometers which use InGaAs-PD with 512 elements 
have a wavelength resolution of about 1.56 nm when covering 900–1700 nm range. On 
the other hand, the newly developed detector, having the PD with one of the world’s 
highest density, enables wavelength resolution of below 1.25 nm. Moreover, thanks to 
the combination with a highly-integrated charge amplifier array circuit, measurement 
speed of the detector is higher by two orders than that of existing PD array detectors. 
The developed spectrometer is small (120 mm × 220 mm × 200 mm) and light (6 kg), and 
it contains various key devices including the high-density and high-sensitivity PD array 
detector, NIR technology and spectroscopy technology for a spectroscopic analyzer that 
has the required detection mechanism and high sensitivity for powder measurement, as 
 26
well as a high-speed measuring function for blenders. Moreover, the characteristics of the 
developed NIR spectrometer were evaluated, and the measurement of powder samples 
confirmed that it has high functionality. 
 27
1. Introduction 
In the pharmaceutical industry, at a worldwide level, the development and approval 
of new drugs is increasingly being governed by common regulations. In this scenario, 
there has emerged the need for a quality assurance method with a strong scientific basis. 
To satisfy this need, the U. S. Food and Drug Administration proposed process analytical 
technology (PAT) for the design, analysis, and control of pharmaceutical manufacturing 
processes through the timely measurement of the critical process parameters that affect 
the final product quality. This technique is expected to replace conventional validation 
techniques and realize improved manufacturing efficiency and quality control of 
pharmaceuticals.1–4 
PAT is used to analyze the manufacturing process, determine the factors essential for 
understanding the manufacturing process, and clarify variable factors that affect quality 
control. At the same time, it is important to improve the manufacturing process based on 
the results of PAT. From these viewpoint, real-time measurement is essential. Toward this 
end, spectroscopy, in particular, near-infrared (NIR) spectroscopy, has attracted 
considerable interest because it affords several advantages such as noncontact and 
nondestructive measurements and availability of remote detection by optical fiber.5–10  
The Fourier transform method is widely used in NIR spectrometers; this method 
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obtains the spectrum by the Fourier transform of interference signal data acquired while 
changing the optical path length.7 It needs a wavelength standard, and therefore, it has 
very high wavelength accuracy. Moreover, in principle, it has superior optical throughput. 
Finally, various improvements have recently been made to the drive mechanism of the 
variable optical length, data processing, and so on. The monochromator-type 
spectroscopic method is also widely used in NIR spectrometers; this method is a 
wavelength dispersion method.8 In this method, the wavelength is continuously swept by 
changing the angle of the diffraction grating. The advantages of this method are the high 
dynamic range and high wavelength resolution. However, it does have some 
disadvantages, such as the long measurement time, large size, and lack of robustness 
owing to the wavelength being swept mechanically. The laser-scanning-type method is 
used to sweep the emission wavelength by varying the current or the external cavity. 
Although the measurement wavelength area is limited to the range of laser emission, this 
method has advantageous features such as high dynamic range and high wavelength 
resolution. In this method, multiple lasers with different emission wavelength regions are 
required to cover the measured NIR wavelength region. The method which uses a 
polychromator employs a spatial wavelength dispersion device, and it enables detection 
over a wavelength region by using a multichannel detector. Unlike in the 
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monochromator-type method, this method simultaneously detects multiple beams over a 
wavelength region. The number of channels in the multichannel detector determines the 
wavelength resolution. This method has advantageous features such as high-speed 
measurement, robustness, and compactness owing to the non-mechanical moving 
architecture.9 
These methods involve specific advantages and disadvantages, and it is necessary 
to select one that is most suitable for use as an in-line analyzer. Generally speaking, this 
PAT application requires features such as high-speed measurement, compact size, and 
maintainability (if possible, maintenance-free). The polychromator-type method provides 
these features; however, its wavelength resolution is inferior to that of other methods. If 
the wavelength resolution of this method could be improved, it would become the best 
method for in-line spectroscopy. To improve the wavelength resolution of this method, it 
is necessary to increase the pixel number of the photodiode array (PDA);10 the pixel 
number of PDA also determines the PDA device size. The spectrometer size increases in 
proportional to the PDA device size. In other words, both wavelength resolution 
improvement and device miniaturization can be achieved by increasing the pixel number 
and density of PDA.  
In the present study, we have developed a new PDA detector that combines a 
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high-density array with a charge-amplifier-array-type integrated circuit (IC). It holds 
PDA with one of the world’s highest density (20-µm pitch) and unusual high speed (~10 
ms). This novel detector has allowed us to improve the wavelength resolution and 
detection sensitivity of the polychromator-type NIR spectrometer (P-NIRs). We have 
designed a new P-NIRs using this PDA as well as an improved optical probe to improve 
the sensitivity. The wavelength resolution and sensitivity of the P-NIRs were evaluated 
through the measurement of a powder sample, and its applicability to an in-line 
monitoring process was examined through the measurement of a powder mixture process.  
 
2. Development of High-density and High-sensitivity PDA Detector 
2.1 High-density PDA 
The detector consists of a high-density PDA containing 640 elements with 20µm 
pitch. InGaAs photodiodes with a wavelength sensitivity of 900–1700 nm 
(photoreceptive sensitivity: 0.8 at 1550 nm) are used. The wavelength resolution of the 
NIR spectrometer which uses the new PDA with 640 elements is 60% higher than that 
of a conventional high-specification NIR spectrometer that has a PDA with 256 
elements. If a measurement wavelength region is 900–1700 nm, the wavelength 
resolution is 3.1 nm for a spectrometer with a PDA having 256 elements while it is 1.25 
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nm for that with the 640 elements. Figure 1-1 shows a diagram of a part of the newly 
developed PDA. This is a PN-junction-type PDA. The substrate structure of the 
photodiode is formed by growing an InGaAs optical absorption layer on an InP-based 
substrate by epitaxial growth and then growing an InP cap layer on the InGaAs optical 
absorption layer. Moreover, an InP buffer layer is formed between the InP substrate and 
the InGaAs photoabsorption layer. An SiO2 mask pattern is formed in order to form the 
640-element PDA with 20 µm pitch and 10 µm photoreceptive width on the substrate. 
Zn is diffused into the obtained substrate to form a high-density PN-junction-type PDA. 
The PDA converts the energy of incident light into a photocurrent. The photocurrent is 
output to the outside with a metallic pad. The PDA may suffer from fluctuations in the 
current output owing to light energy entering between two adjacent PDs. To prevent 
these fluctuations and to improve sensitivity, an optical cover material was placed 
between adjacent PDs.11-13 Figure 1-1 shows a chart of the electrode pattern of the PDA. 
The 640 elements in the PDA are divided into two sets of 320 elements based on 
whether the pixel number is even or odd. Moreover, the bonding pads are arranged in a 
staggered manner with a two-step arrangement. In this manner, the array density could 
be increased. 
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2.2 Charge Amplifier Array Silicon Integrated Circuit 
A charge-amplifier-array-type Si-IC that amplifies the photocurrent converted by 
the 640-element PDA was also newly developed. Figure 1-2 shows a block diagram of 
the charge-amplifier-array-type Si-IC. It consists of a 320-element charge amplifier array 
that is highly integrated to match with a PDA with world top class density, a sample hold 
circuit, a shift register circuit, and a timing generator circuit. A photocurrent from the 
photodiodes charges the integral capacitor, and the electric charge is converted into a 
voltage by the charge amplifier. The output voltage can be calculated by Eq. (1).  
 
( )
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   (1) 
where, Vs [V], Is [A], Id [A], Tc [s], and Cf [F] indicate the output voltage, signal current, 
dark current, charge time, and integral capacitance, respectively. 
The charge amplifier can maintain a high dynamic range by having, and selecting 
two integral capacitors (that have value of 0.5 pF and 10 pF).  All elements of the charge 
amplifier array work completely at the same time by the clock synchronous method that is 
controlled by the timing generator circuit. The charge time is controlled based on the 
external input pulse width. The signal of each element after charging was completed is 
held by the sample hold circuit, following which each signal is read one-by-one by the 
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shift register circuit at high speed. The bonding pad arrangement of the 
charge-amplifier-array type Si-IC is the same as that of the PDA.  
Existing PDAs individually acquire the photocurrent signal converted by each element by 
using an external amplifier, and therefore, they require a measurement time of 
sub-seconds to detect the signal level. In contrast, the newly developed PDA acquires the 
photocurrent signal converted by each element simultaneously using the 
charge-amplifier-array-type Si-IC, and therefore, it requires a measurement time of less 
than 10 ms. 
 
2.3 Photodiode Array Detector 
Figure 1-3 shows the newly developed photodiode array sensor. An AlN substrate was 
selected owing to its good heat conduction and other features. At its center, it contains 
640 InGaAs photodiode elements with 20-µm pitch, which we believe to be the highest 
density reported thus far in the world, on both sides of the substrate, and the newly 
developed charge-amplifier-array-type Si-IC is mounted on top of this. The substrate is 
mounted on a ceramic package via a thermoelectric cooler and is sealed with a cap with a 
sapphire window after filling with N2. 
To evaluate the sensitivity and speed of the PDA, the noise characteristics were 
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evaluated. The light receiving surface was shaded, and 100 measurements were carried 
out with an operation temperature of 25 °C, charge time of 10 ms, and integral 
capacitance of 0.5 pF. The root mean square noise voltage (Vrms) of each pixel was 
calculated from the measured data, and the root mean square noise current (Irms) of each 
pixel was calculated by Eq. (1). Figure 1-4 shows a plot of the root mean square noise 
current of each pixel. The root mean square noise current of each pixel in the PDA was 
less than 0.03 pA. Moreover, the noise equivalent power (NEP) was calculated by Eq. (2). 
 S
I rmsNEP =
  (2) 
where, the photoreceptive sensitivity S is 0.8 A/W at 1550 nm. In all pixels, NEP was 
less than 0.0375 pW, demonstrating that the newly developed PDA can detect even a 
feeble light. 
 
3. Design of NIR Spectrometer 
3.1 Development of Polychromator-type NIR Spectrometer 
In the present study, we developed two types of P-NIRs: one with an optical fiber 
interface (FIF) model with a diffuse reflectance (DR) optical fiber probe for remote 
measurement, and the other with a direct interface (DIF) model with a built-in DR 
optical fiber probe. Figures 1-5 and 1-6 show the FIF and DIF, respectively. Both 
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P-NIRs consists of a polychromator equipped with a PDA detector, an internal optical 
source (halogen lamp, power consumption 5 W), an 18-bit analog to digital (AD) 
convertor for signal conversion and CPU, a data interface, a power supply (battery and 
external source), and a DR optical fiber probe. The optical fiber for irradiating light is 
connected with a built-in optical source, and the optical fiber for receiving light 
diffuse-reflected from a sample is connected with the spectrometer. Figure 1-7 shows a 
schematic diagram of the P-NIRs spectroscopy system, and Table 1-1 summarises the 
specifications of this system. A halogen lamp is used to irradiate the samples with NIR 
light through the optical fiber. The optical fiber comprises a bundle of ~100 optical 
fibers with a core diameter of 190 µm. The DR light enters the spectrometer through the 
optical fiber, and it is dispersed by the diffraction grating device. The dispersed light is 
irradiated on the PDA by a condensing lens. The PDA output is converted by the 18-bit 
AD converter and the CPU carries out calculation processes such as the averaging on it. 
Thereafter, the data sent to a control computer as spectrum data. 
The targeted measurement performance of the P-NIRs is inspection of the process 
line in 10 ms. Toward this end, the P-NIRs employs a high-speed AD converter (1×106 
samples/s), a digital signal processor, and parallel processing of data. Separately, the 
P-NIRs has functions such as the wireless data interface, battery operation, and external 
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synchronous sampling of data. The P-NIRs is controlled by a control computer through 
a serial or a wireless communication protocol. The P-NIRs receives instructions (control 
commands) from the control computer, and executes the spectral measurement, process 
data, and transfer data. The absorption spectrum is displayed and saved on the control 
computer. 
 
3.2 Spectro-engine of P-NIRs 
Figure 1-8 shows the spectro-engine of P-NIRs. The light diffuse reflected from a 
sample is collimated by the collimator lens, and collimated light enters the diffraction 
grating. The light is diffracted into beams of each wavelength. The light is focused onto 
the pixels of the PDA by using a focusing lens in conjunction with a mirror. The 
intensity of the beams of each wavelength is detected by the PDA, and the spectral data 
are obtained through signal processing. 
 
3.3 Diffuse Reflectance Optical Fiber Probe for High Sensitivity 
In the present study, a DR optical fiber probe was also newly developed for 
convenient and sensitive spectral measurement. This optical fiber probe consists of the 
condensing lens and the optical fiber bundle. The lens condenses the irradiating light and 
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the light diffuse-reflected from the sample. By changing the focusing distance of the 
condensing lens, one can flexibly vary the working distance between the probe and the 
sample. The optical fiber bundle is an assembly of optical fibers that transmits the 
irradiating and diffuse reflection lights. The optical fiber bundle is bunched together at 
one end, and it is separated into the optical fibers for the irradiating light and the optical 
fiber for the diffuse reflection light at the other end.  
The irradiating light intensity increases as the caliber of optical fiber increases, 
and the detection property improves, on one hand it also leads to an increase in the 
mechanical fragility. The optical fiber bundle was selected and the composition was 
examined, to achieve a certain mechanical strength, a sufficient light intensity and a 
high optical wavelength resolution. One of the best solution to achieve this is the 
combination of the multimode fiber for detection and a large number of high numerical 
aperture, small diameter, optical fibers for irradiation. About 100 optical fibers of its 
guiding diameter of 200mm allowed us to realize a certain mechanical strength, 
adequate diameter and a high efficiency. 
A DIF model spectrometer was developed that has a built-in DR probe shown in Fig. 
6, for the direct installation to a rotation blender the DIF model has a three-axis 
accelerometer to detect its posture, wireless data interface and lithium ion batteries. 
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4. Experimental 
4.1 Evaluation of Wavelength Resolution 
To demonstrate importance of the wavelength resolution and detection sensitivity 
of P-NIRs, the DR-NIR spectra of talc (Mg3Si4O4 (OH)2, Kanto Chemical Co., Inc.) was 
measured by using the DR optical fiber probe (FIF model). The distance between the 
probe and the talc powder was approximately 50 mm, the sampling time was 30 ms, and 
averaged spectrum calculated from 10 spectra was obtained; the total acquisition time 
for one spectrum was 0.3 s. Moreover, a halogen lamp (5 W) was used as the light 
source. 
The NIR spectra generally have two major drawbacks: band overlaps are severe 
and the baseline fluctuation of the spectra is often considerable. The second-derivative 
pretreatment of the spectra is essential for overcoming these problems. If the 
wavelength resolution of an obtained NIR spectrum is low, it is difficult to separate 
overlapping bands because the spectrum is distorted. Therefore, the band separation 
result by the second-derivative pretreatment is also affected by the wavelength 
resolution. Thus, we have assumed that one can evaluate the wavelength resolution by 
calculating the second derivative of the spectrum. 
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To evaluate the wavelength resolution of P-NIRs, that of the NIR spectrum obtained 
with a 1 nm wavelength resolution was decreased to 5 and 10 nm by the simple moving 
average method. These spectra were subjected to the second-derivative treatment by the 
Savitzky-Golay method (smoothing point: 11 point).14 
 
4.2 Blending Monitoring Test 
To evaluate the high speed performance of P-NIRs, we measured the dynamic 
mixture spectra of talc and D-mannitol (HOCH2 (CHOH)4 CH2OH, Kanto Chemical Co., 
Inc.) during rotation mixing with the DIF model of P-NIRs. Monitoring powder 
blending process by using NIR spectroscopy has been investigated,15-17 because it is 
highly desired to detect the homogeneity of mixed powder. The outline of the blending 
test setup is shown in Figure 1-9. When DR method is used to measure a spectrum, it is 
highly desirable to keep an irradiation distance constant, however powder under mixing 
always moves and the irradiation distance changes largely during spectral measurement. 
Therefore, high speed is highly requested for the NIR spectral measurement in blending 
process.  
The 2-L glass bottle is connected with the clump ferrule of the DIF model of P-NIRs. 
The center of rotation is in the connected part, and the rotation speed is 12 rpm. First, a 
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300 g of talc was put into the glass bottle, and then, a 700 g of D-mannitol was added on 
the talc sample. When P-NIRs is in the bottom position the mixture sample in the bottle 
reaches the optical window (sapphire), so this timing is adopted as a measurement point. 
The spectral measurement is performed by detecting the measuring points by the 
built-in three-axis accelerometer during rotation. The sampling time was 30 ms, and 
averaged spectrum calculated from 30 spectra was obtained; the total acquisition time 
for one spectrum was 0.9 s. The light source is a halogen lamp of only 5 W.  
 
5. Results and Discussion 
5.1 Change in Spectral Shape in the Second Derivative Spectra with Difference 
in Wavelength Resolution 
Figure 1-10 shows the second-derivative spectra of talc with wavelength resolution of 
1, 5, and 10 nm. It yields a sharp peak at 1392 nm owing to the first overtone stretching 
mode of the OH group.18 The second-derivative spectrum with 1-nm wavelength 
resolution measured by P-NIRs shows a narrow band shape, but the second-derivative 
spectrum with 5 nm and 10 nm wavelength resolution show a broad band shape. 
Moreover, in the second-derivative spectrum with 10 nm wavelength resolution, the 
peak intensity decreased to one half of that of obtained with 1-nm wavelength resolution. 
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It has been found that the low wavelength resolution exerts a large influence on the 
band separation performance. Thus, it has been confirmed that high wavelength 
resolution is very effective for the band separation in certain application. And, it has 
been shown that the wavelength resolution of the newly developed P-NIRs is 
sufficiently high. In general, NIR spectral measurements do not require as high a 
spectral resolution as that required by IR and Raman spectral measurements. However, 
in the case of pharmaceutical applications high wavelength resolution is needed because 
pharmaceutical industry requests high precision analysis and high precision 
discrimination of raw materials. Moreover, DR method often needs a pretreatment such 
as second derivative, where wavelength resolution controls analysis performance as 
shown in Figure 1-10. Therefore, NIR spectrometers for PAT should have high 
wavelength resolution, and P-NIRs is equipped with a high wavelength resolution 
required for PAT application. 
 
5.2 Blending Process Monitoring Test of the Modeling Tablet 
Figure 1-11 shows some DR-NIR spectra of the D-mannitol and talc mixture, 
measured during rotation mixing. Because of high speed of P-NIRs, we could obtain 
spectral data at each rotation. The spectrum at 0 s reflects D-mannitol only, and the 
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bands at 1495 and 1580 nm are owing to the first overtones of the OH and CH 
stretching vibration modes. As spectral variations during rotation mixing, both the 
change in spectral shape and the baseline drift were observed. In general, baseline drift 
in DR-NIR spectra during powder mixing is mainly caused by the mean particle size 
and surface condition. Therefore, it is considered that the baseline fluctuation reflects 
change in the mean particle size of mixture powder at the irradiated area. 
Figure 1-12 shows the second-derivative of the spectra shown in Figure 11. These 
spectra were subjected to the second-derivative treatment by the Savitzky-Golay method 
(smoothing point: 31 point). In the original spectra baseline changed largely, while in 
the second-derivative spectra were observed relative intensity changes between the band 
at 1392 nm due to talc and those at 1495, 1580 nm arising from D-mannitol. After the 
mixing for 200 s, the variation of the baseline of the original spectra converged. Also, 
the variation of second-derivative of 1392, 1495 and 1580 nm converged. 
Figure 1-13 shows a plot of a 5 point moving block standard deviation of peak 
intensities at 1392, 1495, and 1580 nm in the second-derivative spectra versus time. 
During the initial stage of mixing, the power sample in the bottle is inhomogeneous, and 
therefore, the spectra, in which bands mainly due to either D-mannitol or talc are 
dominant, are detected at every measurement, causing a high standard deviation value. 
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As mixing proceeds, the sample becomes homogeneous; then, the spectra of the 
mixtures of D-mannitol and talc as the mixing ratio are detected, and thus, the variation 
of absorbance decreases, yielding a low standard deviation value. The results shown in 
Fig. 13 that the standard deviation gives a constant value of 200 s after the start of 
rotation mixing. Thus, it is very likely that the sample in the bottle becomes 
homogeneous after 200 s. The sample homogeneity was confirmed by an existing 
method carried out for a sample taken from a bottle by offline measurement, and it is 
found that the developed P-NIRs enables in-line monitoring of mixing samples. These 
results demonstrate that this P-NIRs has high speed and sufficiently compact for 
realizing in-line monitoring in pharmaceutical processes. 
 
6. Conclusion 
We have developed one of the world’s highest density and high-sensitivity array 
detector to realize a compact, high-resolution, high-sensitivity, and high-speed 
polychromator-type NIR spectrometer. The P-NIRs shows improved wavelength 
resolution and high sensitivity by the use of the newly developed PDA detector with 640 
elements. Existing NIR spectrometers have PDA detector with at most 512 elements, 
and thus their wavelength resolution is at best 1.56 nm. However, the developed novel 
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PDA detector has allowed one to reach wavelength resolution of 1.25 nm or even better. 
Moreover, the combined use of the PDA detector with the developed charge-amplifier 
array has shortened the measurement time from ca. 3 s to below 10 ms.  
Through a mechanical investigation and prototyping of a remote DR detection 
mechanism required for in-line monitoring of the pharmaceutical process, introduction of 
high-speed data processing, and addition of functions such as a wireless interface, we 
have developed a prototype model of a high-speed spectrometer for in-line use and 
confirmed its performance. In PAT, where one must monitor timely quality parameters 
and functional properties of pharmaceuticals during their manufacturing process, 
P-NIRs having high speed is a very suitable NIR spectrometer. Moreover, because of its 
small size, it is very easy to set it up at various pharmaceutical process lines. We have 
confirmed that P-NIRs have achieved high speed, high sensitivity and high resolution 
by measuring the DR-NIR spectra of D-mannitol and talc in the powder state.. 
Moreover, we have shown that P-NIRs can be used to evaluate the homogeneity of the 
mixed powder samples through the in-line monitoring of the mixed states of the powder 
samples. 
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Figure 1-1 Part of the 640-element PDA. 
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Figure 1-2 Block diagram of PDA: (A) 320-element charge amplifier array, (B) 
sample hold circuit, (C) shift registor circuit, and (D) timing generator circuit. 
Two ROICs and one PDA are assembled by the wire bonding method. 
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 Figure 1-3 Outline view of photodiode array sensor. 
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 Figure 1-4 Plot of root mean square noise current of each pixel. 
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Figure 1-5 Fiber interface model of P-NIRs equipped with diffuse reflectance probe. 
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Figure 1-6 Direct interface model of P-NIRs. (A) Optical window through which 
the irradiating and the diffuse reflected light are transmitted. 
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Figure 1-7 Spectroscopic analyzer configuration: (A) spectroscope with a PDA 
detector, (B) internal optical source, (C) 18-bit analog/digital convertor for 
signal conversion and CPU, (D) data interface, (E) power supply (battery 
and external source), and (F) optical fiber probe. 
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Table 1-1   Specification of P-NIRs 
 
Item Fiber-Interface model Direct-Interface model 
Spectral range 900 ‒ 1700 nm 
Wavelength resolution 1.25 nm 
Wavelength accuracy < 0.1 nm 
Absorbance noise level < 0.1 mAbs. 
Sampling time Min. 1 ms/spectrum 
Measurement interval Min. 10 ms 
Number of PD elements 640 elements 
Optical interface Optical fiber input 
Direct: through an optical 
window 
Data interface 
Serial communication: RS232C, USB 
Wireless LAN: 802.11b 
Size 120 mm×220 mm×200 mm 160 mm×220 mm×200 mm 
Weight < 6 kg < 7 kg 
Power supply 
AC / DC, battery 
Typ. 15 W 
Operating temperature +5 – 45ºC 
Operating humidity 5 ‒ 90 %RH 
 
 55
 
 
 
Figure 1-8 Spectro-engine of P-NIRs: (A) collimator lens, (B) diffraction grating, (C) 
focusing lens, (D) mirror, and (E) 640-element PDA. 
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   Figure 1-9 Blending test setup. 
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Figure 1-10 Second-derivative spectra of talc with different wavelength resolutions. 
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 Figure 1-11 DR-NIR Spectra of the D-mannitol and talc during mixing. 
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Figure 1-12 Second-derivative spectra of the D-mannitol and talc during mixing. 
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Figure 1-13 Plots for standard deviation of the second-derivative absorbance at 1392, 
1495, and 1580 nm versus time. 
 
 
61 
 
 
Chapter 2 
 
Feasibility Study of Diffuse Reflectance and 
Transmittance Near-Infrared Spectroscopy for 
Rapid Analysis of Ascorbic-Acid Concentration 
in Bilayer Tablets using High-speed 
Polychromator-type Spectrometer 
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Abstract 
Feasibility of real-time release testing of bilayer tablets was investigated using 
near-infrared (NIR) spectroscopy. The newly developed polychromator-type NIR 
spectrometer was used to compare the diffuse reflectance (DR) and transmittance (Tr) 
NIR spectroscopic techniques. This spectrometer not only performs highly sensitive 
NIR measurements but also affords the NIR spectra of an intact tablet in a millisecond 
(ms)-time scale; i.e., 500 ms for the DR-NIR measurements and 400 ms for the Tr-NIR 
measurements. The bilayer tablets were prepared with the first layer comprising 0–10% 
ascorbic acid (AsA), 20% corn starch, 5% talc, 30% microcrystalline cellulose, and 45–
35% lactose, and second layer comprising 20% corn starch, 5% talc, 30% 
microcrystalline cellulose, and 45% lactose; their DR- and Tr-NIR spectra were 
acquired from both the sides of the tablet. With the help of the obtained spectra, the 
feasibility of DR- and Tr-NIR spectroscopy for the quantitative analysis of AsA in the 
bilayer tablets was compared. The DR- and Tr-NIR spectra of the bilayer tablets and 
their second derivative spectra were studied. The AsA bands were not identified in the 
DR- and Tr-NIR spectra. However, the AsA bands at 995 and 1458 nm were observed in 
the second-derivative spectra. All the developed regression models predicted the AsA 
concentration and regression vectors indicated that the prediction was based on the AsA 
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bands. In addition, the model using the Tr-NIR spectra could predict the AsA 
concentration, even when the bilayer tablet was flipped. 
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1. Introduction 
Since the introduction of process analytical technology (PAT) by the United States 
Food and Drug Administration,1 near-infrared (NIR) spectroscopy has been attracting 
attention as a powerful PAT tool.2-5 The advantages of NIR spectroscopy, such as 
nondestructive and in situ analysis and analysis using an optic fiber,5 are suitable for the 
implementation of NIR measurements in industrial plants. Owing to the increased focus 
on NIR spectroscopy, novel and unique NIR spectrometers and their applications in PAT 
have been developed recently.6-11 Genkawa et al. developed an online NIR and 
mid-infrared (online NIR/mid-IR) dual-region spectrometer, which enables the 
sequential acquisition of the NIR and mid-IR spectra (10,000–1200 cm-1).6 Monitoring 
of fermentation processes and band assignment of water and liquid oleic acid were 
performed with the online NIR/mid-IR spectrometer.6,7 Murayama et al. developed a 
high-sensitivity and high-resolution photodiode array (PDA) detector and a high-speed 
polychromator-type NIR spectrometer (P-NIRs).8 Ishikawa et al. combined an imaging 
unit with the P-NIRs for the development of a compact NIR-imaging device with high 
speed and high portability (D-NIRs).9,10  
In this study, the rapid analysis of ascorbic acid (AsA) concentration in a bilayer 
tablet was investigated using P-NIRs. The P-NIRs was used to investigate the feasibility 
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of the real-time tablet release, namely 100% inspection, during the tablet-making 
process, which is one of the most important goals of PAT using NIR spectroscopy.  
Extensive research has been conducted on the qualitative and quantitative 
analyses of active pharmaceutical ingredients (APIs) in intact tablets using NIR 
spectroscopy.11-28 The advantages of diffuse reflectance (DR) and transmittance (Tr) 
spectral-acquisition methods were reported.18-25 The advantages and disadvantages of 
both the methods are summarized as follows: The DR-NIR method is robust against 
sample positioning errors, which is advantageous for online NIR measurements. For the 
analysis of tablets, the DR-NIR spectra allows the utilization of a wide region of 
wavelength, while the spectral range with wavelengths greater than 1400 nm are 
unavailable in the Tr-NIR spectra. On the other hand, the Tr-NIR spectra reveal 
information about the entire tablet, whereas the DR-NIR spectra reveal information only 
about limited regions on the tablet surface. At low API concentrations, the prediction 
precision of the Tr-NIR method is better than that of the DR-NIR method. 
Hence, the DR- or Tr-NIR method can be chosen based on the distribution of 
analytes in the tablet. For example, the DR-NIR method is desirable when the API is 
homogeneously distributed in the tablet. On the other hand, the Tr-NIR method may be 
applied when the API is heterogeneously distributed in the tablet such as a bilayer tablet. 
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A bilayer tablet can be used to achieve the following: 1) controlling the release rate of 
two APIs, and 2) separating two incompatible substances. Otsuka and Fukui measured 
the Tr- and DR-NIR spectra of bilayer tablets containing the polymorphic forms of 
carbamazepine.27 They reported that the calibration models developed for the 
determination of polymorphic content based on the Tr-NIR spectra had a linear 
relationship unlike those based on the DR-NIR spectra. Ito et al. developed calibration 
models for acetaminophen and caffeine anhydrate contents in a bilayer tablet by using 
the Tr-NIR spectra.28 They reported that the developed calibration models exhibited 
sufficient linearity and accuracy and that it was not necessary to keep the irradiated side 
of the tablet for Tr-NIR analysis.  
As mentioned above, the analysis of tablets by NIR spectroscopy has been 
extensively researched. Most of the research was performed for laboratory use with the 
help of Fourier-transform and monochromator-type spectrometers;12-16,18-21,23-28 in some 
cases, portable NIR spectrometers were used.17,22 Generally, the spectra obtained from 
laboratory-use spectrometers have high signal-to-noise ratios (SNR). However, the 
laboratory-use spectrometers require larger spectral scanning times; consequently, the 
spectral measurement of a sample takes several seconds. However, for real-time tablet 
release testing, a high-speed NIR spectrometer, which enables the acquisition of Tr-NIR 
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spectra on a millisecond (ms)-time scale, is preferred. Because the absorptivity in the 
short-wave NIR region (900 nm – 1300 nm) is very low for most of the samples, the 
Tr-NIR spectrum of an intact tablet (up to 5-mm thick) can be obtained. However, 
compared to the DR-NIR method, longer exposure and scanning times are required for 
the Tr-NIR method to achieve an SNR similar to that of the DR-NIR method. For 
real-time release testing, reliable spectral acquisition on a ms-time scale is preferred. 
The P-NIRs was developed to achieve ms-spectral acquisition.8 The P-NIRs is equipped 
with a novel PDA detector that combines a high-density array (640 InGaAs photodiodes 
with 20-µm pitch) and a charge amplifier array-type integrated circuit that covers the 
900–1700-nm range with a point to point resolution of 1 nm. The noise level of the 
P-NIRs is less than 0.0001 absorbance units and the configurable measurement interval 
is 10 ms. With P-NIRs, it is possible to investigate the feasibility of real-time release 
testing of a tablet using the Tr-NIR spectroscopy and compare it with that of the 
DR-NIR spectroscopy. 
In this study, the DR- and Tr-NIR spectra of the bilayer tablets were acquired on a 
ms-time scale (500 ms for DR-NIR and 400 ms for Tr-NIR spectra) by using the P-NIRs 
and partial least-squares regression (PLSR) for the development of the API 
concentration models. From the results of these regression models, the feasibility of 
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rapid analysis of APIs in a bilayer tablet was investigated. This study compares the DR- 
and Tr-NIR spectra of bilayer tablets obtained on a ms-time scale by using a portable 
NIR spectrometer. Thus, the present study is a step toward real-time release testing of 
bilayer tablets by NIR spectroscopy. 
 
2. Materials and Methods 
2.1 Sample Preparation 
AsA (Kanto Chemical Co. Inc., Tokyo, Japan), lactose (Wako Pure Chemical 
Industries, Ltd., Osaka, Japan), talc (Kanto Chemical Co. Inc.), corn starch (Wako Pure 
Chemical Industries, Ltd., Osaka Japan), and microcrystalline cellulose (Merck KGaA, 
Darmstadt, Germany) were used to formulate the bilayer tablets. All the reagents used 
were of analytical grade. AsA was used instead of an actual API component in the 
present study. 
 
2.2 Bilayer Tablet Preparation 
The sample bilayer tablets were prepared by the pressure bonding method with a 
single-punch tableting machine (Handtab-100, Ichihashi Seiki Co. Ltd., Kyoto, Japan). 
The first layer of the tablet contained AsA (0–10% at 2% intervals) and the second layer 
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did not contain AsA. In addition to AsA, the first layer contained corn starch (20%), talc 
(5%), microcrystalline cellulose (30%), and lactose (45–35% according to the AsA 
concentration). Because the second layer did not contain AsA, the lactose concentration 
in the second layer was 45%.  
Firstly, the powdered samples required for each layer were weighed separately in an 
analytical balance and were blended well in a plastic bag. Then, the powder for the first 
layer was set in the cavity of a tableting machine and was compressed with a rod under 
a gauge pressure of 10 MPa. Instead of measuring the tablet weight, the quantity of the 
blended powder was adjusted by setting the depth of the cavity so that the thickness of 
the first layer became 1.0 ± 0.1 mm. After confirming the thickness, the powder for the 
second layer was added on the first layer in the cavity of the tableting machine and was 
compressed under the same gauge pressure. The tablets with a thickness of 2.0 ± 0.1 
mm, which is the typical thickness range for commercial tablets, were selected and 30 
bilayer tablets (six AsA concentration levels, five tablets each) were prepared for the 
experiments. 
 
2.3 NIR Spectrometer 
Recently developed P-NIRs8 was used for the spectral acquisition on a ms-time scale. 
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Two types of P-NIRs models are available: (i) an optical fiber interface model with a 
DR optical fiber probe, and (ii) a direct interface model with a built-in DR optical fiber 
probe. The optical fiber interface model was used in this study. Details of this 
spectrometer are described in a previous report.8 
 
2.4 Spectral Data Acquisition 
The NIR spectra of the 30 bilayer tablets were measured on both the sides (from the 
first to the second layer and from the second to the first layer) by the Tr- and DR-NIR 
methods. Figure 2-1 illustrates a schematic diagram of the spectral acquisition. A bilayer 
tablet was placed in the tablet holder and NIR light was irradiated from a halogen lamp 
(5 W) located 55 mm above the tablet. In the DR-NIR measurement, an optical 
detection probe was set at an angle of 20° to prevent the effect of specular reflection, 
and a DR standard (SRS-99-020, Labsphere, Inc., USA) was used as the background 
reflectance material. The sampling time for obtaining one spectrum was set as 50 ms 
and an average spectrum was calculated from 10 spectra; the total acquisition time for 
one tablet was 500 ms. In the Tr-NIR measurement, the optical detection probe was 
positioned directly beneath the tablet and NIR light transmitted through the tablet was 
measured. To measure the background spectrum, diffuse transmittance plates of 1-mm 
71 
 
thickness (ZDF-1000, Labsphere, Inc., USA) were stacked in pairs and used. The 
sampling time was 400 ms; averaging was not performed. In both the measurements, the 
NIR spectra in the 900–1700 nm region were measured with a point to point resolution 
of 1 nm. The optimal sampling times for each method were determined from 
preliminary experiments. In these experiments, the DR standard and diffuse 
transmittance plates were used and a sampling time that provided the maximum signal 
intensity without detector saturation was chosen. In addition, 10 spectra were averaged 
for the DR-NIR measurement so that the total acquisition time was almost the same as 
that of the Tr-NIR measurement for the comparison between DR-NIR and Tr-NIR 
spectra. 
 
2.5 Spectral Data Analysis 
The Unscrambler® X ver. 10.2 (CAMO software AS, Norway) was used for the 
pretreatment of spectra and PLSR modeling of AsA concentration. The AsA 
concentration in the tablets was calculated from the weight of AsA, which was obtained 
during tablet preparation. To minimize uncertainties in the tablet preparation, the mean 
spectrum calculated from the NIR spectra of five tablets with the same AsA 
concentration were used for the modeling. Firstly, the DR- and Tr-NIR measurements 
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were converted to the absorbance units, namely log10 (1/DR) or log10 (1/Tr). Then, the 
mean of the five spectra was calculated for each AsA concentration and the spectral 
regions for PLSR modeling were selected by referring to the band assignments of AsA: 
the 1400−1500-nm region for the DR-NIR spectra and the 950−1050-nm region for the 
Tr-NIR spectra (Figure 2-2). In these regions, the AsA bands arising from the second 
and first overtones of the O–H stretching vibration were observed at 995 and 1458 nm, 
respectively.29 Subsequently, the obtained mean spectra were subjected to the Savitzky–
Golay second-derivative treatment.30 The window size of the second-derivative 
treatment was determined by referring to the appearance of the AsA bands at 995 and 
1458 nm in the spectra of tablets, and a second-order polynomial was used, as shown in 
Table 2-1. After mean-centering the second-derivative spectra, the PLSR models based 
on the DR- and Tr-NIR spectra acquired from both sides of the tablet were constructed 
to determine the AsA concentration. The PLSR models were validated by the 
leave-one-out cross-validation method and the coefficient of determination (R2) and 
root-mean-square-error of cross-validation (RMSECV) were calculated. In the present 
study, four PLSR models were constructed: DR 1, DR 2, Tr 1, and Tr 2. The DR 1 and 
DR 2 models were based on the DR-NIR spectra obtained by irradiating NIR light from 
the first and second layers, respectively, and the Tr 1 and Tr 2 models were based on the 
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Tr-NIR spectra obtained by irradiating NIR light from the first and second layers, 
respectively.  
 
3. Results and Discussion 
3.1 Comparison of NIR Spectra and Their Second Derivatives 
To validate the performance of ms-spectral acquisition by P-NIRs and the 
necessity of band separation, the NIR spectra and their second derivatives obtained by 
the DR- and Tr-NIR methods were compared. Figure 2-3 depicts the DR-NIR spectra of 
the bilayer tablets with and without AsA obtained by irradiating NIR light from the first 
(Figure 2-3a) and second (Figure 2-3b) layers. Regardless of the light-irradiated side, it 
was difficult to identify an intensity change in the AsA band in the DR-NIR spectra 
because of band overlapping and baseline fluctuation. Similarly, no change in the 
AsA-band intensity was observed in the Tr-NIR spectra shown in Fig. 2-4. Compared to 
the DR-NIR spectra, the Tr-NIR spectra in the region shorter than 1400 nm are easily 
observed and the spectra in the region longer than 1400 nm are quite noisy. This decline 
in the SNR at the longer-wavelength region is not due to the P-NIRs or ms measurement, 
but it is an unavoidable problem in the Tr-NIR method when tablets with higher 
thickness are used. Similar results have been reported in other studies where the FT-type 
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and monochromator-type spectrometers and higher spectral-scanning times were 
adopted.14,18,19,24,27 
Figure 2-5 shows the second-derivative DR-NIR spectra of the bilayer tablet and their 
expansion in the 1440–1480-nm region. The second-derivative spectra are spiky 
because of the high wavelength resolution of P-NIRs (1 nm) and noise enhancement by 
the derivation. However, an intensity change in the band at 1458 nm due to AsA is 
clearly observed. The intensity of this AsA band in the DR 2 spectrum (Figure 2-5b) is 
smaller than that in the DR 1 spectrum (Figure 2-5a), because DR light is attenuated 
during its passage through the first-layer side. The second-derivative Tr-NIR spectra of 
the bilayer tablet are shown in Figure 2-6. The band at 1458 nm is not observed because 
of the decline in the SNR in this wavelength region. Instead, a significant band-intensity 
change, which is related to the AsA concentration, is found at 995 nm. The amount of 
spectral variations with AsA concentration is similar between the spectra of Tr 1 and Tr 
2. Unlike the DR-NIR method, the tablet side from which the light is irradiated need not 
be confirmed in the Tr-NIR method.  
 
3.2 Comparison in PLSR Models 
To identify the feasibility of rapid analysis of API in a bilayer tablet, validation 
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results of the PLSR modeling for AsA concentration in the first layer are evaluated. 
Table 2-1 summarizes the analysis conditions and cross-validation results of the PLSR 
models. All the PLSR models achieved an R2 greater than 0.87 and RMSECV lesser 
than 1.6%. The models DR 1 and Tr 1, which used the spectra obtained by irradiating 
NIR light from the first-layer side, showed slightly better results than those using 
spectra obtained by irradiating the light from the second-layer side (models of DR 2 and 
Tr 2). As shown in Figure 2-7, the RMSECV decreases drastically with the first and 
second latent variables (LVs) and becomes almost constant after the second LV. These 
results indicate that all the constructed regression models describe changes in the AsA 
concentration with the first and second LVs based on the spectral change due to AsA 
and not noise signal. Therefore, the NIR spectroscopic technique combined with PLSR 
modeling enables the prediction of the API concentration in a bilayer tablet by using the 
NIR spectra obtained on a ms-time scale. To enable the practical use of this technique, 
further investigations are required for optimizing the spectral acquisition and analysis 
method conditions. 
Regression vectors of the models were used to interpret the obtained PLSR models. 
Figure 2-8 shows the regression vectors of the PLSR models. In the regression vector of 
the DR 1 model (Figure 2-8a), the band at 1458 nm has the largest regression 
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coefficient; however, no prominent regression coefficient is obtained in that of the DR 2 
model (Figure 2-8b). Hence, the DR 1 model is based on the intensity change of the 
AsA band at 1458 nm, whereas the DR 2 model is based on the intensity change of the 
AsA band as well as other components. Despite observing an intensity change with AsA 
concentration in the DR 2 spectra (Figure 2-5b), the DR 2 model is less accurate than 
the DR 1 model (Table 2-1). In contrast, the regression vectors of the models obtained 
using the Tr-NIR spectra indicate that the largest regression coefficient is obtained at the 
995-nm band because of AsA (Figures 2-8c and 2-8d), and both the regression models 
are based on a change in the AsA concentration, which is similar to the DR 1 model. 
However, large positive coefficients were observed at 1473 and 1022 nm (Figures 2-8a 
and 2-8d), which probably result because of a decrease in the prediction accuracy of the 
DR 1 and Tr 2 models. Further investigations are required for improving the SNR of 
these bands. 
Besides the feasibility of nondestructive measurement of API in a bilayer tablet, the 
advantages of the Tr-NIR method while turning over the bilayer tablet were investigated. 
Figure 2-9 shows the comparison of the predicted AsA concentrations with their actual 
values when the AsA concentrations were predicted by inserting the spectral data set of 
DR 2 to the DR 1 model or Tr 2 to the Tr 1 model. The AsA concentrations predicted by 
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using the Tr-NIR method are in agreement with the actual concentrations, whereas those 
predicted by using the DR-NIR method are lower than the actual concentrations. The 
maximum difference between the predicted and actual values is 5.3% for the tablet with 
10% AsA. This result supports the results of previous studies that a Tr-NIR method is 
useful for the quantitative analysis of a bilayer tablet.26,27 For the DR-NIR method, an 
identification algorithm such as Hotellings T2 or F-Residuals will be advantageous in 
detecting the direction of the bilayer tablet to avoid orientation issues of the bilayer 
tablet when used in the actual production environment. 
 
4. Conclusion 
In this study, the feasibility of the analysis of API in a bilayer tablet on a ms-time 
scale using NIR spectroscopy was investigated. The newly developed P-NIRs, which 
enables the high-speed spectral measurement of an intact tablet, was used. The NIR 
spectra of the bilayer tablets were acquired by both th DR- and Tr-NIR methods at 500 
and 400 ms to obtain the DR- and Tr-NIR spectra, respectively.  
Comparison of the NIR spectra with their second-derivatives showed that the NIR 
spectra were specific and selective to variation in the AsA concentration. The validation 
results and regression vectors demonstrated that the PLSR models enabled the 
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prediction of the AsA concentration in the bilayer tablet. The Tr-NIR method was 
confirmed to be fairly robust for tablet orientation. Thus, the present study is a step 
toward the real-time release testing of bilayer tablets. 
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Table 2-1. Analysis conditions and cross-validation results of PLS models 
Model 
Wavelength 
region (nm) 
Window size of 
second-derivative 
Number of 
LVs 
R2 RMSE (%) 
DR 1 1400–1500 13 2 0.89 1.3 
DR 2 1400–1500 13 2 0.87 1.6 
Tr 1 950–1050 25 2 0.93 1.1 
Tr 2 950–1050 25 2 0.88 1.4 
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Figure 2-1. Schematic diagram of the spectral measurement system. 
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Figure 2-2. Second-derivative DR-NIR spectra of AsA and lactose powder samples. 
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Figure 2-3. DR-NIR spectra of the bilayer tablets with and without AsA; spectra 
obtained by irradiating light from (a) the first and (b) second layer sides. 
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Figure 2-4. Tr-NIR spectra of the bilayer tablets with and without AsA; spectra obtained 
by irradiating light from (a) the first and (b) second layer sides. 
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Figure 2-5. Second-derivative DR-NIR spectra of the bilayer tablets with and without 
AsA; spectra obtained by irradiating light from (a) the first and (b) second 
layer sides. 
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Figure 2-6. Second-derivative Tr-NIR spectra of the bilayer tablets with and without 
AsA; spectra obtained by irradiating light from (a) the first and (b) second 
layer sides. 
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Figure 2-7. Relationship between the RMSECV and latent valriables.  
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Figure 2-8 Regression vectors of PLS model; (a) DR 1 model, (b) DR 2 model, (c) Tr 
1 model, and (d) Tr 2 model.  
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Figure 2-9 Comparison of predicted value of AsA concentration with actual value.  
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Chapter 3 
 
Application of a Newly Developed Portable 
NIR Imaging Device to Dissolution Process 
Monitoring of Tablets 
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Abstract 
We have recently developed a novel portable NIR imaging device (D-NIRs), which 
has high speed and high wavelength resolution.  This NIR imaging approach has been 
developed by utilizing D-NIRs for studying the dissolution of a model tablet containing 
20 % ascorbic acid (AsA) as an active pharmaceutical ingredient (API) and 80 % 
hydroxypropyl methylcellulose (HPMC), where the tablet is sealed by a special cell. 
Diffuse reflectance (DR) NIR spectra in the 1000 – 1600 nm region were measured 
during dissolution of the tablet. An unique band at around 1361 nm of AsA was 
identified by the second derivative spectra of tablet and used for an NIR imaging of 
distribution of AsA in it. Two-dimensional change of AsA concentration of the tablet 
due to water penetration is clearly shown by using the band-based image at 1361 nm of 
NIR spectra obtained with high speed. Moreover, it is significantly enhanced by using 
the intensity ratio of two bands at 1361 and 1354 nm corresponding to AsA and water 
absorption, respectively, showing the dissolution process. The imaging results suggest 
that the amount of AsA in the imaged area decreases with increasing water penetration. 
The proposed NIR imaging approach using the intensity of a specific band or the ratio 
of two bands combined with the developed portable NIR imaging instrument, is a 
potentially useful practical way to evaluate the tablet at every moment during 
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dissolution and to monitor the concentration distribution of each drug component in the 
tablet.   
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1. Introduction 
Process analytical technology (PAT) is a system that controls quality during 
pharmaceutical manufacturing process.1-4 The goal of PAT is to ensure final product 
quality. In-process quality control requires the non-contact, non-destructive, and 
high-speed techniques. Near-infrared (NIR) spectroscopy combined with chemometrics 
techniques satisfy these requirements and thus attract attention as a useful PAT tool.5 
Therefore, it has been widely applied to evaluate quantity and quality of tablets. For 
each pharmaceutical process such as blending, granulation, drying and coating, a 
number of publications have reported ways to predict quantity of components, evaluate 
particle size, show the distribution of mixed components, and so on.5-12 To make PAT 
more realistic, it is highly desirable to develop NIR instruments with high speed and 
high wavelength resolution. Moreover, their portability is very important for 
overcoming the constraints of space in practical situations. Thus, many innovative NIR 
spectrometers, which satisfy the technical requirements such as high speed and high 
accuracy, have been developed.13,14 Our research group has also provided a newly 
developed NIR spectrometer named P-NIRs.15 1 nm wavelength resolution 
measurement with high accuracy is possible by the developed detector of P-NIRs.15,16  
Thus, P-NIRs seems to be very suitable for various purposes of PAT. 
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As one of the approaches to product performance of pharmaceutical process, the idea 
of quality by design (QbD) has also been proposed.17-19 For QbD of the oral medication, 
the monitoring and evaluation of the tablet dissolution process is very important. 
Conventional dissolution tests in vitro (USP – United States Pharmacopeia) have been 
performed to evaluate the release and dissolution of active pharmaceutical ingredient 
(API) from a dosage formulation. However, these dissolution tests are destructive, 
time-consuming, and only yield a total amount of dissolved drug for one tablet or 
several tablets. Moreover, it does not provide direct insight into the internal structure 
and the mechanism of drug release during the dissolution, such as water sorption and 
drug diffusion. 
In recent years, therefore, a number of novel imaging approaches have been proposed 
to monitor the behavior of a pharmaceutical tablet during dissolution.17-21 These new 
approaches specifically study tablet dissolution based on two or three-dimensional 
monitoring by several spectroscopic imaging such as visible (Vis) and FTIR 
spectroscopic imaging. Bettini, et al (2001) described the physical changes of a tablet 
upon water intake using visible photography.17 However, visible images and images 
based on them are only surface sensitive, so that these data do not provide correct 
qualitative and quantitative insights. FTIR spectroscopic imaging with high quantitative 
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and chemical sensitivity is superior to visible imaging in many aspects.18 FTIR imaging 
has also shown that obtaining information on the spatial distribution of components 
during dissolution over time is possible.19  Therefore, Kazarian and Van der Weerd 
(2008) investigated differences in the release time between components during tablet 
dissolution by using both FTIR-ATR and visible images to assess the mechanism of 
tablet dissolution and drug release.20,21  
For the NIR region, although Hattori and Otsuka (2011) reported an NIR study of an 
interaction during the penetration of water into a tablet using a combined method of two 
dimensional correlation spectroscopy (2DCOS) and perturbation-correlation moving 
window (PCMW) method,22,23 they did not describe the characteristics of the 2D spectra 
during the dissolution. Development and application of NIR imaging based on 
polychromator type spectrometer for industrial situation is relatively slow compared 
with FTIR spectroscopic imaging, though NIR imaging has some advantages over FTIR 
imaging.24,25 NIR imaging can use an optical fiber and non-contact mode, and it is very 
suitable for probing thick samples. Therefore, it is very likely that NIR imaging is 
powerful for distribution analysis of a tablet and monitoring of tablet dissolution, which 
is an application that can be studied with the development of NIR imaging. The NIR 
imaging has advantages for distribution monitoring in a tablet and NIR imaging devices 
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are widely used for laboratory based analysis.25-29 The ability to visualize and the 
quantitative result for concentration with high accuracy during tablet dissolution were 
provided.28,29 However, NIR imaging devices which are available in the practical 
situation are still under developing, so that the evaluation method of tablet dissolution 
with clear visualization has not been fully established. Especially, to our best knowledge, 
there has been no portable NIR imaging system as pharmaceutical industrial monitoring 
tool. 
In the present paper, therefore, an application of a novel portable NIR imaging device 
(D-NIRs) to monitor the dissolution process of tablets is reported.30 D-NIRs is a 
compact 151 mm × 93 mm × 120 mm portable NIR imaging instrument. It allows 
imaging with relatively high speed (in the case of 1 mm spatial resolution, 50 seconds 
speed per 100 pixel), high wavelength resolution (1 nm), and maximum spatial 
resolution (0.025 mm per pixel). This instrument is useful not only for PAT, but also for 
other various industrial applications. We demonstrate the potential of this instrument in 
monitoring dissolution processes of tablets. We can visualize a tablet dissolution process 
and probe proceeding variations in the concentrations of tablet components using a 
single wavelength based imaging or a ratio of intensities of two bands based imaging. 
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2. Materials and Methods 
2.1 Sample 
Powder samples of ascorbic acid (AsA, Kanto Chemical Co, Ltd., Tokyo, Japan) and 
hydroxypropyl methylcellulose (HPMC, Wako Pure Chemical Industries, Ltd., Osaka, 
Japan) were used as materials for analytical tablets. Both of the reagents used were of 
analytical grade. Chemical structures of AsA and HPMC are illustrated in Figure 3-1. In 
the present study, instead of an actual API component, AsA was defined as the API. The 
average particle sizes of AsA and HPMC were 300 and 80 µm, respectively.  
The sample tablets composed of 20 w% AsA and 80 w% HPMC were prepared by 
pressure bonding method with a single punch tableting machine (Handtab-100, 
Ichihashi Seiki Co. Ltd., Kyoto, Japan). Thickness of each tablet was 1.0 mm ± 0.1 mm, 
and its diameter was ⌀ = 8 mm. 
 
2.2 NIR Imaging Device 
In the present study, a newly developed portable NIR imaging device (D-NIRs) for 
collection of NIR spectra was used. The design and performance of D-NIRs are reported 
in our previous article.30 Although the maintenance space of D-NIRs including a NIR 
spectrometer (P-NIRs), an imaging unit and a power source unit is 250 mm × 100 mm × 
120 mm, the portable imaging unit requires only 191 mm × 93 mm × 120 mm in space. 
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The optical system of D-NIRs depends on P-NIRs, which is equipped with a 640 
elements high density photo diode detector and a charge amplifier.15,16 It can obtain 
spectra in the 1000 – 1600 nm region with a 1 nm spectral resolution in just a few 
seconds. Moreover, P-NIRs has a high portability (250 mm × 100 mm × 120 mm), and 
thus, P-NIRs itself has a high efficiency for application of process monitoring.  
The imaging unit of D-NIRs consists of light sources and a pair of Galvano-mirror 
(approximately 2 mm × 2 mm). D-NIRs uses three halogen lamps of 5 W to acquire the 
sufficient incident energy for the collection of high accuracy spectral data. Each incident 
light focuses on a sample, and DR light obtained from the sample reaches 
Galvano-mirrors. These mirrors move to the direction of x- and y-axis, respectively, by 
two motors, and then the two dimensional spectral imaging data in the whole spectral 
region between 1000 – 1600 nm are obtained by a line scanning system. Although the 
available maximum measurement area of D-NIRs is 10 mm × 10 mm, the focused area 
is 6 mm × 6 mm because of the constraint of the location of three lamps. However, the 
design based on the combination of lamps and mirrors not only contributes to the 
portability of D-NIRs but also enables high-speed data acquisition at approximately 50 
sec/100 pixels (in the case of 1 mm spatial resolution). The maximum spatial resolution 
of D-NIRs achieves 0.025 mm/pixel due to the special mechanical design for focus. 
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2.3 Tablet Cell Design 
The construction of a developed tablet cell is shown in Figure 3-2 (a). The cell 
consists of two cover metals (top and bottom) onto which transparent BaF2 windows are 
fixed. A tablet is clamped between the two windows. It is surrounded by a Teflon spacer 
that is slightly thicker than the tablet, so that a sealed compartment is formed. Water is 
supplied from the top hole of the cell and reaches the side of tablet through the hole on 
the top window. As shown in Figure 3-2 (b), this cell is set on a sample stage of 
D-NIRs.  
Figure 3-3 displays visible images of tablet dissolution measured at 0 and 300 min 
from the start of water supply. Because the top metal has Ѐ10 mm cavity area in the 
center part, two-dimensional NIR spectral image of the tablet can be acquired through 
the cavity using D-NIRs.  
 
2.4 Measurement Conditions and Spectra Acquisition 
DR spectra in the 1000 – 1600 nm region of each pixel in a tablet were obtained by 
D-NIRs. Each measurement was carried out with about 20 min interval, and a field of 
view (FOV) was 10 mm × 10 mm. A spatial resolution (pixel size) was determined to be 
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300 µm, which corresponded to the average particle size of AsA. The NIR spectra 
acquisition was started immediately after water had been supplied into the cell, and the 
spectra measurement was continued up to 300 min. The tablet cell was positioned in the 
direction of the D-NIR from the mirror of D-NIRs as shown in Figure 3-3 (b). A 
working distance of 55 mm between the tablet and D-NIRs was maintained throughout 
all spectral measurements. The charge time for each measurement was 30 msec, and 100 
repetitions for each time were carried out to ensure adequate accuracy of the spectra 
obtained from the tablet. 
 
2.5 Data analysis 
The spectral data was collected with Image controller (ver. 10.16, Yokogawa, Co. 
Tokyo, Japan) software and transferred into files for the Unscrambler (ver. X: CAMO, 
AS, Trondheim Norway) software. The obtained DR spectra were converted to spectra 
with absorbance (log(1/Dref)) values, where Dref is the diffuse reflectance obtained from 
the sample.31 This absorbance was calculated by based on Kubelka-Munk formation that 
describes about relation among absorbance, diffuse reflectance and scattering of 
incident light. To search for an informative spectral region and/or a specific band by the 
effect of band separation, these spectra were subjected to a second derivative procedure 
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(21 points), including Savitzky-Golay smoothing of 2nd order polynomial.32 A 
two-dimensional spectroscopic image was obtained by plotting the 2nd derivative 
intensities located at 1361 nm in the two-dimensional plane. 
 
3. Results and Discussion 
3.1 NIR spectra of AsA and HPMC in powder forms 
Figure 3-4 shows NIR spectra in the region of 1000 – 1600 nm of powdered AsA, 
HPMC and water subjected to baseline offset procedure of water. The water was 
purified by Ultrapure water system (PureLab/PureLite PRB-002A, ORGANO, Co., 
Tokyo, Japan). It was dropped on the micro slide grass, and its spectrum was measured, 
individually. The spectrum of water was obtained by applying shorter charge times than 
those of others to avoid the saturation of spectrum. A broad absorption band of water in 
the 1400 - 1550 nm region is assigned to the first overtone of OH stretching, 
combination of OH symmetric and antisymmetric stretching modes.33 Although a band 
associated with the OH stretching mode also appears in the spectrum of HPMC, it is 
completely overlapped with the water band.34 In addition, a small broad absorption in 
the region of 1100 – 1300 nm is assigned to the second overtones of CH stretching 
vibrations of HPMC.35 On the other hand, narrow bands of AsA at around 1361 and 
1451 nm may be due to the first overtones of stretching vibrations of free and 
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inter-molecular hydrogen-bonded OH groups, respectively.36 A broad absorption in the 
1150 – 1250 nm region of AsA may also be assigned to CH stretching vibrations.36 
 
3.2 NIR spectra and their second derivative spectra of sample tablets during 
dissolution process 
NIR spectra and their second derivative spectra of the tablet at a point of X: 4.5 mm, 
Y: 1.5 mm during dissolution process are shown in Figure 3-5 (a) and (b), respectively. 
For the location of this point, an example of NIR image developed by the intensity of 
the absorbance at 1361 nm is shown in Figure 3-5 (c). The absorbance of a broad band 
in the 1400 – 1600 nm region increases with the expansion of bandwidth (Figure 3-5).  
It is found from the second derivative spectra that three bands exist at 1451, 1432, and 
1420 nm in this region. However, a major reason for the intensity increase is water 
absorption because it increases with elapsed time. A time-dependent change in the 1150 
– 1300 nm region is not clear. Recognition of the band at around 1361 nm from the 
original spectra was not so easy, because it exists as a shoulder band. However, it is 
possible to identify it as an unique band of AsA from the second derivative spectra.  
Figure 3-6 displays expanded second derivative spectra in the 1380 – 1330 nm region. 
In this region, it is important to note that two bands appear. One of them observed at a 
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shorter wavelength (1354 nm) probably depends on the water absorption because its 
intensity increased with the elapsed time.  To avoid overlapping with the bands due to 
water and HPMC, the band at 1361 nm due to AsA is selected for imaging. 
 
3.3 Single wavelength-based imaging 
Figure 3-7 (a) plots the intensity at 1361 nm of the second derivative spectra at 
several different points in the tablet versus the dissolution time. For reference of these 
points, the NIR images mapped by absorbance at 1361 nm are shown in Figure 3-7 (b). 
At around the center part (X: 4.0 mm, Y: 4.0 mm), the intensity at 1361 nm is almost 
constant, but at other points a linear decrease in the intensity is observed for the whole 
dissolution time. If these observed linear responses would follow the Beer-Lambert law, 
the intensity change of the band at 1361 nm may correspond to the change in the AsA 
concentration in the tablet. 
Figure 3-8 exhibits changes in the distribution of the band intensity at 1361 nm with 
the elapsed time. The image contrast is based on the intensity at 1361 nm, a higher 
intensity corresponding to darker blue. As expected, the color of the right and left 
bottom parts of inside had become brighter than the initial color before the tablet 
dissolution was started. The result, therefore, suggests that the AsA concentration 
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decreases linearly upon water penetration, a phenomenon which could not be observed 
by visible images.  
However, the second derivative intensity of the tablet edge was approximately 0 or 
higher than 0, showing that the concentration of AsA does not change from the initial 
time. As mentioned above, the light sources of D-NIRs focus on the inside of around 6 
mm × 6 mm, so that the intensity of the outside of the focused area of the tablet 
decreases.   
 
3.4 Peak height ratio-based imaging 
In Figure 3-9, images developed by the peak-height ratio of two bands at 1361 and 
1354 nm are given. The intensity ratio of two bands (I1361/I1354) is associated with the 
dissolution process and can avoid the edge effect as discussed above. The difference in 
the contrast of the inside of tablet for the peak-height ratio based image (I1361/I1354) is 
clearly larger than that of the single wavelength based images (cf. Figure 3-8). 
Moreover, as expected, the edge effect that is dependent on the design of the light 
source locations of D-NIRs could be avoided; the contrast of the outside is obviously 
drowned. Hence, it is very likely that the peak-height ratio based imaging is more 
effective than the single wavelength based imaging. In that case, bands used for the 
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peak-height ratio calculation must clearly be understood by second derivative procedure 
as in the case of the present study.  
The results thus obtained may provide a potentially useful practical way to evaluate 
the tablet at every moment during dissolution and to monitor the concentration 
distribution of each component in the tablet. Moreover, although the portability is not 
necessarily required for fundamental investigation of tablet, this feature of D-NIRs will 
allow not only dissolution monitoring but also the industrial application to the 
pharmaceutical process. 
  
4. Conclusion 
The paper has reported an application of a new portable NIR imaging device 
(D-NIRs) in relation to the dissolution process of the tablets for the requiments of PAT 
and/or QbD. NIR spectra in the 1000 – 1600 nm region of the model sample tablets 
containing 20 wt% AsA as an API and 80 wt% HPMC were measured during the 
dissolution process up to 300 min. A band at 1361 nm could clearly be identified in the 
second derivative spectra of the sample tablets as the unique band for AsA. As expected, 
the color contrast in the images of the tablet dissolution had changed before it was 
started, and this result was enhanced significantly by using peak height ratio-based 
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images. The understanding of tablet dissolution processes such as the degree of water 
penetration into a tablet can be advanced by NIR imaging.  
The results obtained in this study have demonstrated that NIR imaging using spectral 
changes, such as the change in the band intensity at 1361 nm and the change in the 
peaks-height ratio, is a powerful tool for the evaluation of the dissolution process of a 
tablet. In the near future, we plan to measure NIR imaging under flow of water and to 
evaluate the improved D-NIRs which are equipped with the four halogen lamps for 
practical tablet dissolution applications. 
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Figure 3-1 Chemical structures of ascorbic acid (AsA) and hydroxypropyl 
methylcellulose (HPMC)  
 
 AsA (C6H8O6) 
 
O
OHOH
HO
HO
H
O
(S) O
OO
RO
OR
RO
RO
OR
OR
n
O
R=-H,-CH3,-CH2-CHOH-CH3
HPMC
119 
 
 
 
 
Figure 3-2 (a) A schematic diagram of the tablet cell, and (b) a photo the picture 
showing the arrangement of the tablet cell and D-NIRs. 
 
120 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3 Visible images of tablet dissolution measured at 0 and 300 min from the 
start of water supply. 
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Figure 3-5 Time
derivative spectra of the tablet dissolution process at a point of 
Y:1.5
the absorbance of 1361 nm due to AsA.
- dependent changes of (a) NIR spectra and (b) their second 
 mm. (c) NIR images of the point mapped at 0, 120, and 240 min by 
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 Figure 3-7 (a) Plots of the second derivative peak intensity at 1361 nm due to AsA in 
the second derivative spectra at several different points of 
mm
and (b) the images mapped at 0 and 240 min using the absorbance at 1361 
nm.
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 Figure 3-8 Changes in the single wavelength based
process developed by using the second derivative intensity at 1361 nm due 
to AsA. These second derivative images were modified by arbitrary 
threshold to delete the color except the t
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 Figure 3-9 Changes in the peak
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arbitrary threshold to delete the color except the tablet part.
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Chapter 4 
 
Image Monitoring of Pharmaceutical Blending 
Processes and the Determination of an End 
Point by Using a Portable Near-Infrared 
Imaging Device Based on a 
Polychromator-Type Near-Infrared 
Spectrometer with a High-speed and 
High-Resolution Photo Diode Array Detector 
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Abstract 
In the present study a new version (ND-NIRs) of a polychromator-type near-infrared 
(NIR) spectrometer with a high-resolution photo diode array detector was developed, 
which a previously constructed (D-NIRs). The new version has four 5 W halogen lamps 
compared with the three lamps for the older version. The new version also has a 
condenser lens with a shorter focal point length. The increase in the number of the 
lamps and the shortening of the focal point of the condenser lens realize high 
signal-to-noise ratio and high-speed NIR imaging measurement. By using the ND-NIRs, 
the in-line monitoring of pharmaceutical blending was carried out and determined an 
end point of the blending process. Moreover, to determinate a more accurate end point, 
a NIR image of the blending sample was acquired by means of a portable NIR imaging 
device based on ND-NIRs. The imaging result has demonstrated that the mixing time of 
8 minutes is enough for homogeneous mixing. In this way the present study has 
demonstrated that ND-NIRs and the imaging system based on a ND-NIRs hold 
considerable promise for process analysis. 
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1. Introduction 
In modern pharmaceutical industries, the idea of new quality management has been 
proposed for the delivery of reliable pharmaceutical products. The idea is the quality by 
design (QbD) approach. QbD is an approach that clarifies the factors which 
significantly influence the quality properties of the medicine from the stage of the 
formulation design and the process design, and it carries out the quality control based on 
a scientific basis.1 Process analytical technology (PAT) is used to analyze the 
manufacturing process, determine the factors essential for understanding the 
manufacturing process, and clarify variable factors that affect quality control.2,3 PAT is 
positioned as a powerful technology to achieve the QbD approach. To evaluate the 
quality of an oral medication, the monitoring of component distribution including that 
of active pharmaceutical ingredient (API) is essential. It is well known that 
spectroscopic technology is attractive for the non-destructive monitoring of 
pharmaceutical tablets.3-11 Evaluation methods for inhomogeneity in a tablet based on 
ultraviolet-visible (UV-Vis) spectroscopy and high performance liquid chromatography 
(HPLC) were developed about two decades ago.10,11 However, the UV-Vis spectroscopy 
methods are usually based on destructive methods, so there are only a few reports on the 
use of UV-Vis spectroscopy in the quantitative analysis of tablet components. Recently 
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a number of research groups have been involved in the development of vibrational 
spectroscopy methods for PAT.4-10 Near-infrared (NIR) spectroscopy in particular has 
attracted keen interest as a powerful PAT method since it has superior features for real 
time monitoring; it is a non-destructive and non-contact method.4,12 Moreover, NIR can 
use optical fibers, allowing remote-sensing. Imaging techniques in the NIR region have 
also been developing.13-19 
In previous studies has been involved in PAT studies through the development of new 
NIR instruments, particularly, imaging instruments.15,19-21 We recently developed a 
distribution type NIR spectrometer (D-NIRs), which is an NIR imaging instrument 
based on a polychromator-type NIR spectrometer with a high sensitivity and 
high-resolution photodiode array detector. The portability of D-NIRs is superior. The 
size of the imaging unit is only 3 liter volume. D-NIRs enables high speed monitoring 
(25 ms/1 pixel) and high wavelength resolution (1.25 nm) of NIR imaging due to the 
newly developed InGaAs detector. The detector consists of a high-density PDA 
containing 640 elements with 20 µm pitch. InGaAs photodiodes with a wavelength 
sensitivity of 900-1700 nm (photoreceptive sensitivity: 0.8 at 1550 nm) are used.20 
A NIR image obtained during the water dissolution process of a tablet demonstrated 
the potential of D-NIRs as a PAT tool.19,22-24 Of course, NIR images of tablets measured 
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by using D-NIRs can clarify the distribution and the relative abundance of chemical 
components in the tablets.15 It was successfully demosntrated that D-NIRs is an 
attractive tool for PAT and that it can be applied for QbD.  
However, evaluation methods for pharmaceutical blending process based on NIR 
imaging are still under development, although the blending process can be monitored by 
NIR spectra10,11,25 and it was reported that NIR imaging technique can be utilized for 
studying the effects of the particle sizes of chemical components on the blending 
process.26 In addition, the end point of the blending process was determined by using a 
NIR imaging technique.27 However, in this case it took long time to get an image and 
also the wavelength resolution was very low. Thus, it would be highly desirable to 
develop a NIR imaging system that enables both high speed and high wavelength 
resolution measurements in NIR imaging. 
Quite recently, as a part of the present study we have built a new type of D-NIRs 
named ND-NIRs. The new type has four 5 W halogen lamps as light sources, that is, 
one more halogen lamp than the original type. In addition, in the scanning unit of 
ND-NIRs the focal length of the condenser lens is shortened to optimize the 
performance of the optical scanning system. The increase in the number of lamps 
together with the shortening of the focal length has enabled about seven times faster 
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imaging measurements compared with the original version. The purpose of the present 
study was to carry out the in-line monitoring of a pharmaceutical blending process and 
the determination of an end point of this blending process by using a ND-NIRs, 
polychromator-type NIR spectrometer with high speed and high wavelength resolution. 
Moreover, to determinate an accurate end point in a short time, a NIR image of the blending 
sample was acquired by means of a portable NIR imaging device based on ND-NIRs. 
 
2. Experimental Section 
2.1 New NIR Imaging Device (ND-NIRs) 
A new version of D-NIRs (Yokogawa Electric Co., Tokyo, Japan) has been developed 
for the collection of NIR imaging spectra. Its imaging unit consists of galvanic mirrors, 
condenser lenses, a rectangular prism, a fiber-optic cable, and four halogen lamps as 
shown in Figures 4-1 and 4-2. There are two significant major differences between the 
original version (D-NIRs) and the new version (ND-NIRs). One is the number of lamps. 
The new version has four 5 W halogen lamps while the old version had only three. This 
increase in the number of lamps increased the light quantity significantly. Another 
important difference between the two versions is the length of the focal point of the 
condenser lens. The length has become significantly shorter in the new version (70 mm) 
compared with that in the old version (100 mm), greatly increasing the captured light 
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quantity. The aperture size of the condenser lens of the new version and the old version 
was same. The increase in the number of the lamps and shortening of the focal length of 
the condenser lens achieve high signal-to-noise ratio, enabling high-speed NIR imaging 
measurement. Figure 4-3 plots a root mean square (RMS) noise of D-NIRs and 
ND-NIRs at the high-light flux. The RMS noise evaluation test between D-NIRs and 
ND-NIRs that was carried out in accordance with the US Pharmacopeia.28 The rms 
noise level of the old version is 0.5 mAbs/0.5 s, while that of the new version is 0.05 
mAbs/0.5 s. The measurement speed of the new version (11 s/100 pixels) has become 
seven times higher compared with that of the original one (80 s/100 pixels). 
It is also notable that the size of the new imaging unit is only 220 mm × 90 mm × 150 
mm due to the contribution of these optimized elements in the imaging unit. The 
irradiation energy from the four halogen lamps reaches a sample, and the diffuse 
reflected light reaches the galvanic mirror. Finally, this signal is detected by a 
spectrometer named P-NIRs through the optical fiber. P-NIRs was also developed as a 
new spectrometer.20 The high speed spectra mapping of 13 s per 25 mm2 area of 
ND-NIRs is due to the P-NIRs. The superior futures of P-NIRs were reported in a 
previous paper.20,21 The maximum scan area of ND-NIRs is 10 mm × 10 mm, and its 
spatial resolution (pixel size) is 25 µm. 
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2.2 Data Collection 
The blending machine was rotated by 15 rpm in 15 min. The spectrometer, P-NIRs, 
was placed under this machine (Figure 4-4), and when the machine returned to the 
original position, the DR-NIR spectrum of blending powder was recorded by P-NIRs. 
The NIR spectra in the 950–1700 nm region were measured with a 1 nm interval, and 
they were converted to CSV format immediately. These spectral data were subjected to 
Savitzky-Golay (SG) smoothing and then to second derivative treatment with 19 point, 
and 2nd order.30 Imaging measurements of DR-NIR spectra were carried out several 
times by using a ND-NIRs. DR-NIR spectra at each pixel were obtained by line 
scanning method, and the peak at 1458 nm due to the first overtone of OH stretching 
vibration of AsA identified by the point measurement was used for the NIR mapping. 
 
2.3 Sample Preparation 
Ascorbic acid (AsA), magnesium stearate and D-mannitol were purchased from 
Kanto Chemical Co., Inc. (Tokyo, Japan), and their powders were prepared for blending. 
These materials were introduced into a vessel type blending machine (Tsutsui Scientific 
Instruments Co., Ltd., Taito-ku, Japan). The outline of the blending test setup is shown 
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in Figure 4-4. To monitor the blending process, each material was added in the order 
D-mannitol, magnesium stearate and AsA. Finally, the prepared powder consisted of 
88% (w/w) D-mannitol, 2% (w/w) magnesium stearate and 10% (w/w) AsA. 
 
3. Results and Discussion 
3.1 NIR Spectra of Ascorbic Acid, D-mannitol and Magnesium Stearate 
Figure 4-5 shows (a) diffuse-reflectance (DR) NIR spectra and (b) the second 
derivative spectra of powder of ascorbic acid (AsA), D-mannitol and magnesium 
stearate in the 950–1700 nm region. Narrow bands of AsA at around 1361 and 1458 nm 
may be due to the first overtones of stretching vibrations of free and intermolecular 
hydrogen-bonded OH groups, respectively.28 A broad absorption in the 1150–1250 nm 
region of AsA may be assigned to the second overtones of CH stretching vibrations.28 A 
broad absorption in the 1490–1590 nm region of D-mannitol may be assigned to the first 
overtones of OH stretching vibrations. 
 
3.2 Evaluation of Inhomogeneity During Blending Process by In-Line NIR 
Spectrometer 
Figure 4-6 shows a series of second derivative spectra of the blending sample 
measured during rotation mixing. The inset of Figure 4-6 depicts the enlargement of the 
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1445–1475 nm region. It is noted that the peak intensity at 1458 nm due to the first 
overtone of the OH stretching vibration mode of AsA changes with time. The band of 
1458 nm is not detected in the initial stage of the mixing. However, this band becomes 
strong as mixing proceeds. The spectrum measured at 0 s reflects D-mannitol only; the 
band at 1495 nm arises only from the first overtone of the OH stretching mode. The 
intensity at 1495 nm becomes weak with mixing. 
Figure 4-7 plots a 5-point moving block standard deviation of the peak intensity at 
1458 nm in the second-derivative spectra versus time. We also prepared similar plot by 
using the band at 1495 nm due to D-mannitol. The 1495 nm band gave similar result to 
the 1458 nm band. It is noted in Figure 4-7 that during the initial stage of mixing, the 
powder sample in the vessel is inhomogeneous, and therefore, the standard deviation 
(SD) value is high. As mixing proceeds, the sample becomes homogeneous. Then, the 
spectra of the mixtures of ascorbic acid, D-mannitol and magnesium stearate as the 
mixing ratio are detected, and thus, the spectral variation decreases, yielding a low SD 
value. The result in Figure 4-7 shows that the SD gives a constant value around 168 s 
after the start of rotation mixing. Thus, it is very likely that the sample in the bottle 
becomes homogeneous after 168 s.  
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3.3 Evaluation of Inhomogeneity during Blending Process by NIR Imaging 
Figures 4-8, 4-9 and 4-10 depict: (a) images for the distribution of AsA and (b) binary 
images for mixing times of 1, 8, and 15 min. A binary image is the two color image, it 
usually consists of white and black color. To determine the color in an image, the 
arbitrary threshold is defined prior to the visualization from the digital numbers and 
intensities, etc of all pixels. Figure 4-8a–c show the second derivative spectra collected 
at different points in the two-dimensional spectroscopic image of the blend sample at 1 
min after the start of blending. In the measurement of two-dimensional spectroscopic 
image of blend sample NIR spectra acquisition, second differentiation treatment, and 
absorbance mapping using specific wavelength were carried out at the same time. The 
ND-NIRs allows the spectral acquisition in 242 s for a measurement area of 5 mm × 5 
mm, spatial resolution 0.1 mm in the wavelength region of 934–1713 nm, with the 
wavelength resolution of 1 nm. In this system the number of data is 2601 pixels × 780 
absorbance data = 202,878 data points. Table 4-1 summarizes the measurement times 
for various measurement conditions. The results in the table demonstrate that ND-NIRs 
can provide imaging spectra data at a high speed. Second derivative spectra of one pixel 
(one point) shown in Figure 4-11 demonstrate that they catch clearly the specific 
absorption wavelength of 1458 nm due to AsA. These results suggest that ND-NIRs has 
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high signal-to-noise ratio and high wavelength resolution, enabling the correction of 
baseline deviation and the band separations without the influence of the increase of noise 
emphasized by the second derivative treatment. Each point spectrum obtained from the 
binary images corresponds well to the spectrum of AsA, showing that the sample existing in 
the points is AsA.  
Area ratios (pixel ratios) of AsA and non-AsA from the binary images were 
calculated, and then estimated the temporal change in the relative amount of AsA. The 
area ratio of AsA in the binary images of imaging spectra at the mixing time of 1, 8, and 
15 min was 1.49%, 9.57%, and 8.74%, respectively. The relative amount of AsA at the 
mixing time of 8 and 15 min was almost the same as that the initial sample throw 
amount (10%). On the other hand, the relative amount of AsA at the mixing time of 1 
min was much smaller, indicating that the mixing is insufficient. From the present result 
we can conclude that the mixing time of 8 min is enough for homogeneous mixing. 
 
4. Conclusion 
A new version of a polychromator-type NIR spectrometer with a high-resolution 
photo diode array detector was developed, which we built before (D-NIRs). The new 
version has achieved a high signal-to-noise ratio and a high speed. The noise level of the 
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new version is 10 times lower than that of the old version, and the measurement speed 
of the new version is seven times higher than that of the original one. By using the new 
version we performed an in-line evaluation of inhomogeneity during a blending process 
and determined the end point for homogeneous mixing. The evaluation of 
inhomogeneity during the blending process was also carried out by NIR imaging. 
Imaging spectra of mixing samples were measured at different times. The NIR imaging 
revealed that the distribution of AsA in the blend sample changes with time. It has 
turned out that the mixing time of 8 min is sufficient for homogeneous mixing. The 
present study has demonstrated that NIR imaging is very useful for further 
understanding of the result of in-line monitoring of blending process. 
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Figure 4-1 Overview of the developed NIR imaging device (ND-NIRs). A: X axis 
galvano mirror, B: Y axis galvano mirror, C: 5 W halogen lamp, D: 
Condensing lens 1, E: Right angle prism mirror, F: Condensing lens 2, G: 
Optical fiber cable.  
 Figure 4-2 Outline of D
Sample plinth with temperature control function
-NIRs. A: P-
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NIRs, B: XY scanning unit, C: control unit, D: 
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 Figure 4-3 A plot for root mean square noise of D
flux. 
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 Figure 4-4 Outline
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 Figure 4-5 (a)
The second derivative of the spectra shown in (
 NIR spectra of ascorbic acid, 
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D-mannitol and magnesium stearate
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 Figure
 
 4-6 The second derivative spectra of mixing sample measured during the 
blending process.  
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Table 4-1  Measurement time for each condition by ND-NIRs. 
 
Measurement Area 5 mm × 5 mm 
Spatial Resolution 1 mm 0.5 mm 0.2 mm 0.1 mm 
Number of Measurement Point 
(Number of Spectra Data) 36 121 676 2061 
Measurement Time 5 s 13 s 64 s 242 s 
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Chapter 5 
 
An application for the quantitative analysis of 
pharmaceutical tablets using a rapid switching 
system between a near-infrared spectrometer 
and a portable near-infrared imaging system 
equipped with fiber optics 
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Abstract 
In this study present a rapid switching system between a newly developed 
near-infrared (NIR) spectrometer and its imaging system to select the spot size of a 
diffuse reflectance (DR) probe. In a previous study, we developed a portable NIR 
imaging system, known as D-NIRs, which has significant advantages over other 
systems. Its high speed, high spectral resolution, and portability are particularly useful 
in the process of monitoring pharmaceutical tablets. However, the spectral accuracies 
relating to the changes in the formulation of the pharmaceutical tablets, have not been 
fully discussed. Therefore, the rapid optical switching system was improved and 
presented a new model of D-NIRs (ND-NIRs). This system can automatically switch 
the optical paths of the DR and NIR imaging probes, greatly contributing to the 
simultaneous measurement of both the imaging and spot. 
The NIR spectra of the model tablets, including 0-10 % ascorbic acid, were measured 
and simultaneous NIR images of the tablets were obtained. The predicted results using 
spot sizes for the DR probe of ⌀1 and ⌀5 mm, resulted in coefficient of determination R2 
= 0.79 and 0.94, with root-mean-square errors (RMSEs) of 1.78 wt% and 0.89 wt%, 
respectively. For tablets with a high concentration of ascorbic acid, the NIR imaging 
results showed inhomogeneity in concentration. However, the predicted values for the 
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low concentration samples appeared higher than the known concentration of the tablets, 
although the homogeneity of the concentration was confirmed. In addition, the optimal 
spot size using NIR imaging data was estimated to be 5 mm to 7 mm. The results 
obtained in this study show that the spot size of the fiber probe, attached to a 
spectrometer, is important in developing a highly reliable model to determine the 
component concentration of a tablet. 
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1. Introduction 
In the past decade, process analytical technology (PAT), a framework developed by 
the Food and Drug Administration, has been widely applied to the pharmaceutical and 
food industry fields.1–5 PAT is a comprehensive control system for pharmaceutical 
production, and includes production design, process analysis, and management.  
It is well known that spectroscopic techniques are one of the most effective methods 
of PAT in pharmaceutical processes.1,4 Ultraviolet-visible (UV-Vis) spectroscopy has 
been used with charge-coupled device detector based instruments. Several research 
groups have reported UV-Vis techniques that are useful in extracting qualitative and 
quantitative information regarding the contents of tablets.6  
Vibrational spectroscopy, for example mid-infrared (mid-IR) and Raman 
spectroscopy, can be used to obtain the intrinsic characteristics of the molecules in the 
components. Therefore, mid-IR and Raman spectroscopy have been used to evaluate the 
physical and chemical properties, such as, the concentration, intra- and inter-molecular 
interactions, and the crystallinity of the products in pharmaceutical processing.7–11 Since 
the mid-IR spectrum enables a clear assignment of bands and has a high quantitative 
performance, extensive research has been performed in the past decade relating to the 
concentrations in samples and reaction monitors.12  Moreover, mid-IR spectroscopy 
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plays an effective role in the polymeric properties of a sample (e.g., crystallization), to 
determine the efficiency of downstream operations (e.g., filtration, drying, and 
formulating) and the product effectiveness.        
Raman spectroscopy is a nondestructive analytical method, with minimal influence 
by water and an easily operatable light fiber. Therefore, Raman spectroscopy is a useful 
tool in pharmaceutical applications.8–9 Raman spectroscopy has been used to evaluate 
the homogeneity of pharmaceutical blending and granulation for in-line process 
analysis.9–10 Raman spectroscopy, in combination with chemometrics, has also been 
utilized as a PAT tool for the in-line and real-time endpoint determinations of several 
different powder blending processes.8–10 
Near-infrared (NIR) spectroscopy has several advantages, such as remote and bulk 
analyses, non-contact, and minimal sample preparation for pharmaceutical process 
monitoring. Moreover, improvements in the instrument, such as higher speeds and light 
fiber optics enhances its applicability for implementation in pharmaceutical process 
monitoring.1,4–5 However, in general, NIR spectra are more complicated than mid-IR 
spectra because the NIR bands are produced by overtones and combinations with many 
overlapping bands. Therefore, the quantitative accuracy is problematic when using 
spectra in the NIR region for process monitoring.4–5,11 More recently, remarkable 
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improvements in NIR imaging instrumentation have enabled the evaluation of 
pharmaceutical powder blend and tablet uniformities, as well as tablet dissolution with 
on-line monitoring systems using the standard deviation of the spectra.13–15 
Generally, the pharmaceutical process is divided into several steps: milling of 
materials, blending, drying, coating, and tableting. The evaluation of the quality at each 
step reflects changes in the physical and chemical properties of the components, 
including the particle size, thickness, moisture content, and inhomogeneity.16–19 
Therefore, to appropriately monitor the target, which changes through various states 
during the process, the measurement conditions, such as the measurement speed, 
wavelength resolution, probe type, and signal-to-noise ratio, should all be adjusted 
according to the changes in the properties of the target.    
Recently, an in-line monitoring NIR spectrometer, P-NIRs, and an NIR imaging 
device, D-NIRs were developed for a pharmaceutical process monitoring.20–22 P-NIRs 
can obtain NIR spectra in the 950 – 1700 nm region at a spectral resolution of 1.25 nm. 
D-NIRs are composed of P-NIRs, an imaging unit, and a light source unit. D-NIRs can 
measure 900 mm2 area with a 100 µm spatial resolution. We note that, for an area of 
100 mm2, a spectrum in the 950-1700 nm range can be obtained within less than 10 s.  
Another innovative feature of D-NIRs is the portability of the instrument.21–22 
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Although a working space of 25×30×30 cm3 is required to use D-NIRs, the size of the 
P-NIRs and the imaging unit of D-NIRs, are only 20×20×10 and 25×20×17 cm3, 
respectively. In addition, D-NIRs enable simultaneous quantitative and distribution 
monitoring using the same spectrometer. This feature is very useful in process 
monitoring, and it show that D-NIRs can be used to obtain the quantity and distribution 
of the concentrations of the components of a tablet during process monitoring.20–23 It 
also present the determination method for the blending process when using the 
D-NIRs.21 Moreover, Ishikawa et al. demonstrated the potential of D-NIRs as an 
important monitoring tool of the tablet dissolution process.23 In a previous study also 
showed that combination of chemometrics with principal component analysis (PCA) 
and partial least squares regression (PLSR) enabled the application of P-NIRs in 
highly-accurate and high-speed tablet internal measurements.19–23 
However, the optimization of NIR spectroscopy for use in process monitoring is still 
under consideration. One of the problems of NIR spectroscopy is that the differences of 
the spot sizes in the DR probes, constrains their use in practical applications in the 
pharmaceutical process as these generate differences in the spectral accuracies. 
Therefore, this study aims to explore a rapid switching system of P-NIRs and D-NIRs, 
equipped with fiber optics, to be applied in the process of monitoring pharmaceutical 
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tablets. NIR spectra using P-NIRs, and NIR imaging using D-NIRs, for the on-line 
monitoring of the tablets were measured. Also, the application potential of D-NIRs in 
the on-line monitoring of pharmaceutical tablets through the optimization of the beam 
size of the fiber probe was evaluated. 
 
2. Instrumentation 
A schematic diagram of the spectral measurement system, an imaging probe 
(D-NIRs), and an in-line type NIR spectrometer with a diffuse reflection (DR) probe are 
shown in Figure 5-1. The spectral measurement system can switch between the DR 
probe and imaging probe optical paths automatically, using an optical switching device. 
A sample tablet was placed on a tablet holder of the D-NIRs system. The DR light 
reached the DR optical fiber probe connected with the P-NIRs, and the NIR spectra in 
the 950 - 1700 nm region was obtained at various points in the tablet. The spectral 
resolution was 1.25 nm, and the integration time was 1 s. Other details of the D-NIRs 
system were described in previous studies.12,21 The DR optical fiber probe consisted of a 
condenser lens and an optical fiber bundle. The detection and incident fibers were 
bundled into the new probe at a high density. Consequently, the newly developed optical 
fiber probe achieved mechanical strength with a sufficient light intensity.20 In the 
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present study, the optimum spot size of the DR probe was investigated, by developing 
⌀1 and ⌀5 mm beam size probes which were connected to the P-NIRs. 
The DR light reaches the imaging unit, consisting of an area scan mirror unit and an 
irradiation light unit. The two-dimensional measurement in the 950 - 1700 nm region 
was obtained though the DR optical fiber. The spatial resolution of the imaging was 0.1 
mm. Note that the one-spot and two-dimensional spectra were obtained only at 1 and 
900 s by the system, respectively. In the newly developed system, the measurements of 
the one-spot and two-dimensional spectra were obtained by easily switching the optic 
fiber connection. The optical switch module AQ2200-412 (Yokogawa Electric Corp., 
Tokyo, Japan) was used. AQ2200-412 performed the switching of the optical paths with 
high accuracy. Therefore, the optical switching module mechanically operated the 
optical ports using a high positioning accuracy stepping motor and rotary switching 
mechanism.24 The spectral noise of the switching system was evaluated. Figure 5-2 
shows the spectral noise of the DR and imaging probes measured by the optical switch. 
The DR and imaging probes have a high signal-to-noise ratio (SNR) of 0.0001 in an 
absorbance unit. 
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3. Material and Methods 
3.1 Sample preparation 
The sample tablets were prepared using a powder of 0-10 wt% ascorbic acid (Kanto 
Chemical Co. Inc., Tokyo, Japan), 35-45 wt% lactose, 20 wt% corn starch, 30 wt% 
cellulose, and 5 wt% talc, which were placed in a plastic bag, mixed for 5 minutes, 
and the obtained mixture was pressed at 10 kN by a tableting machine (Handtab-100, 
Ichihashi Seiki Co. Ltd., Kyoto, Japan). Eleven sample tablets were obtained, with 
different concentrations of ascorbic acid and lactose, and the diameter and thickness of 
each tablet were ⌀8 mm and 1.0 mm, respectively. The shape of the sample tablets 
were flat. Five samples were prepared for each concentration to ensure adequate 
accuracy, and consequently, 55 samples were used in the quantitative analysis. 
 
3.2 Spectral collection 
For the point measurements, the DR spectra in the 950 - 1700 nm region were 
obtained from the central part of a tablet. The DR probe was inclined 15° with respect 
to the tablet samples. A 5 W halogen lamp was used, with an integration time of 1 s. 
Two-dimensional simultaneous spectra measurements were obtained by switching the 
optical probe. The field of view of an image was 10×10 mm2, with a spatial resolution 
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of 100 µm. The measurement procedure was then performed. First, the point 
measurements were obtained by the DR probe. Then, the imaging measurements were 
obtained by the imaging probe, after switching the optical path using the optical 
switching module. 
 
3.3 Spectral analysis 
The spectra obtained from the D-NIRs were transferred to text format and analyzed 
by Unscrambler Ver. 10.3. The spectra were subjected to a second derivative procedure 
with 21 points, including Savitzky-Golay smoothing.25 A partial least squares (PLS) 
regression was applied to these spectra to determine the concentration of the ascorbic 
acid. The data from the 55 samples were used to build the calibration model with PLS 
regression. The accuracy of the models were determined using full cross validation.  
 
4. Results and Discussion 
4.1 NIR spectra of ascorbic acid, lactose, corn starch, cellulose, and talc 
Figure 5-3 shows the DR spectra and their second derivative spectra in the 950 - 1700 
nm region of ascorbic acid, lactose, corn starch, cellulose, and talc. The bands around 
1354 and 1458 nm of ascorbic acid were due to the first overtones of the stretching 
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vibrations of the free and intermolecularly hydrogen-bonded OH groups, respectively.26 
The bands in the 1150 - 1250 nm region of ascorbic acid are due to CH stretching 
vibrations. The peak at 1391 nm for talc was associated with the first overtone of the 
OH stretching mode.27 Cellulose, starch, and lactose also contain numerous OH groups, 
with similar corresponding bands.  
 
4.2 Determination of the accuracy of the concentration 
Figures 5-4 and 5-5 display the DR spectra and their second derivative spectra in the 
950 - 1700 nm region of the tablet samples measured by the DR probes with 1 and 5 
mm spot sizes. In the NIR spectra obtained by the DR probe with the 1 mm spot, the 
band intensity for the 1400 - 1600 nm region varied largely compared to that obtained 
with the 5 mm spot. Moreover, the variations in the second derivative spectra collected 
by the DR probe with the 1 mm spot were also more prominent than those obtained by 
the DR probe with the 5 mm spot, over the whole region. The difference between the 
maximum and minimum values of the secondary differential intensity of 1458 nm (AsA 
absorption band peak) of the spectrum obtained with the ⌀1 mm spot size was 0.00025. 
Moreover, the difference between the maximum and minimum values of the secondary 
differential intensity of 1458 nm of the spectrum obtained with the ⌀5 mm spot size was 
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0.00012. In particular, for the probe with the ⌀5 mm spot, the average spectra obtained 
from the wider area of the tablet contributed to a reduction in the variations. These 
variations may have arisen from the differences in the particle sizes between ascorbic 
acid and the other excipients. The area dependence of the spectrum is more prominent 
in the absorption band region of ascorbic acid, 1400 - 1600 nm, for the probe with the 1 
mm spot. 
Therefore, the spectra collected by the (smallest) ⌀1 mm spot probe restricted the 
quantitative analysis results of the concentrations due to the area dependence. The 
analysis conditions, results of the PLS, and the predicted concentration of ascorbic acid 
are listed in Table 5-1. The determination accuracies of the ⌀1 and ⌀5 mm spot size 
probes were described by the determination coefficients of 0.79 and 0.94, with RMSE 
of 1.79 wt% and 0.86 wt%, respectively. As expected, the improvement of the 
determination accuracy was dependent on changes in the spot size. 
Figure 5-6 shows the average values in the concentrations predicted by PLS 
regression. In addition, Table 5-2 shows the standard error of concentrations predicted 
by PLS regression. In the whole region, the error values obtained by the ⌀1 mm spot 
probe were higher than those obtained by the ⌀5 mm spot probe. The spectral noise did 
not differ between the point and imaging measurements using the switching system. 
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Therefore, the switching system was useful to utilize the same spectrometer for both the 
point and imaging measurements. In Figure 5-7, panels (A), (B), and (C) show the NIR 
images obtained by mapping the predicted values of the ascorbic acid concentration 
using the PLS prediction models, for the data collected using the ⌀5 mm spot size probe. 
In the tablet sample of Figure 5-7 (A), the predicted concentration value of AsA 
obtained by the ⌀1 mm spot probe was 7.8 wt%. In the tablet sample of Figure 5-7 (B), 
the predicted concentration value of AsA obtained by the ⌀1 mm spot probe was 14.8 
wt%. Conversely, in the tablet sample of Figure 5-7 (C), the predicted concentration 
value of AsA obtained by the ⌀1 mm spot probe was 9.1 wt%. The concentration value 
of AsA was low in the central area of the NIR imaging data of Figure 5-7 (A). Therefore, 
the AsA concentration was low in the area measured by the ⌀1 mm spot probe. The high 
concentration area of the NIR imaging data of Figure 5-7 (B) was clearly observed in 
the area measured by the ⌀1 mm spot probe. The concentration value of AsA was 
dispersed in the whole area of the NIR imaging data of Figure 5-7 (C). Therefore, the 
concentration value of AsA was the average concentration in the area measured by the 
⌀1 mm spot probe. In the case of the ⌀1 mm sample spot, the data strongly reflected the 
inhomogeneity of the tablet. Therefore, these results revealed that the particle size 
and/or blending time may be used to determine high concentrations. In addition, the 
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⌀1–9 mm circular spot average AsA concentration values of each sample's NIR imaging 
data were calculated, and a plot of the difference between each circular spot average 
AsA concentration value with the ⌀5 mm spot average reference value is shown in 
Figure 5-8. The spot average AsA concentration values for ⌀1–3 mm were higher than 
the ⌀5 mm spot average AsA concentration value. Conversely, the spot average AsA 
concentration values for ⌀5–7 mm were almost the same as the ⌀5 mm spot average 
AsA concentration value, which is a plateau region for the ⌀5–7 mm range. Moreover, 
the spot average AsA concentration values for ⌀8–9 mm were lower than the ⌀5 mm 
spot average AsA concentration value. Therefore, the optimal spot size for measuring 
the AsA concentration was estimated to be between ⌀5–7 mm by the dispersibility and 
average AsA concentration values obtained from the NIR imaging data. Furthermore, 
the DR spectra of the tablet samples were collected using the ⌀9 mm spot probe, and a 
PLSR analysis was performed. The determination accuracy of the ⌀9 mm spot probe is 
described by the determination coefficient of 0.37 with a RMSE of 2.61 wt%. This 
result is lower than the determination accuracy for the ⌀5 mm spot size due to the fact 
that background light noise from around the tablet sample is collected because the spot 
size is larger than the tablet sample. Therefore, the quantitative analysis of the AsA 
concentration in the tablet samples with a ⌀5 mm spot size is more appropriate. 
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Conversely, the value obtained by the ⌀1 mm spot probe implied a large dispersion in 
the known concentration in the tablet. The homogeneity of the NIR imaging obtained 
from the high ascorbic acid concentration tablet was similar to the predicted 
concentration of ascorbic acid obtained by the ⌀5 mm probe. The spectra measured by 
the ⌀1 mm spot probe may have contained a relatively high level of noise due to 
contaminants, although the distribution of ascorbic acid was homogeneous. To avoid 
overestimation, not only improvements in the band separation of the spectral 
pre-treatment are needed, but also the acquisition of a sufficient signal for process 
monitoring. In NIR spectroscopy-based monitoring, these are the obstacles faced in 
cases of low concentrations. However, the results obtained by the probes with different 
spot sizes successfully demonstrated that an optimized spot size can improve and 
contribute to the prediction accuracy of the concentration of tablets. 
 
5. Conclusion 
In order to simplify the probe design and the development of in-line type NIR 
spectrometers, we have developed an optical fiber switching system using a DR probe 
and an NIR imaging device (D-NIRs), which can change the spot size. This switching 
system acquired DR spectra and NIR imaging data with one polychromator type NIR 
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spectrometer (P-NIRs). Therefore, it was possible to evaluate the dispersibility and 
uniformity of a sample by NIR imaging and to evaluate the quality of the spectral data 
obtained by the DR probe. The model tablets, containing 0-10% ascorbic acid as active 
pharmaceutical ingredient (API), were prepared, and NIR spectra in the 950 - 1700 nm 
region were measured using P-NIRs. The optical switching system with D-NIRs and 
P-NIRs was able to collect the DR spectra and NIR imaging data with rapid, 
high-precision, and automatic performance, with a rotary mechanical component optical 
fiber type switching module. The predicted error results for the ⌀1 mm spectra were 
substantially greater than those of the ⌀5 mm spectra. The results showed that the ⌀5 
mm spot size DR probe was superior to the ⌀1 mm spot size DR probe. In addition, the 
optimum spot size for quantifying AsA concentration was estimated to 5–7 mm spot 
size by the NIR imaging data. Moreover, the predicted error results for the ⌀9 mm 
spectra were substantially greater than those of the ⌀5 mm spectra. The results showed 
that the estimation result of the optimum spot size based on the NIR imaging data 
almost agreed with the prediction error results of ⌀1, ⌀5 and ⌀ 9 mm spot size probes. 
An image of the high concentration of ascorbic acid resulted in an inhomogeneous 
distribution. Therefore, the quantitative accuracy depends mainly on the inhomogeneity 
due to the insufficient particle size and blending time. However, the predicted value for 
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the low concentration was higher than the measured value. Therefore, in cases of low 
concentrations, the quantitative accuracy may be determined by using the spectra 
accurately, rather than the inhomogeneity of the component. This study suggested the 
possibility of selecting a more suitable optical fiber probe by using a system that can 
switch between the one-point measurement type optical fiber probe and NIR imaging 
measurement. 
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 Figure 5-1 A schematic diagram of a NIR spectrometer and related optical system, 
and a photograph of the same.
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 Figure 5-2 NIR imaging spectrum noise
plotted by the optical fiber
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 (blue) and NIR DR spectrum noise 
-type switching module.
(red) 
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Figure 5-3 (a) DR spectra and (b) their 2nd derivative spectra in the 950-1700 nm 
region for ascorbic acid, lactose, microcrystal cellulose, starch, and talc 
(b) 
(a) 
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Figure 5-4 (a)DR spectra and (b) their 2nd derivative spectra in the 950-1700 nm 
region of tablet samples measured by a 1 mm spot size DR probe.  
(b) 
(a) 
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Figure 5-5 (a)DR spectra and (b) their 2nd derivative spectra in the 950-1700 nm 
region of tablet samples measured by the 5 mm spot size DR probe. 
(b) 
(a) 
186 
 
Table 5-1  Analysis conditions and results of PLS. 
 
 
 
Model Wavelength Region[nm] R
2 RMSE of Calibration
[%]
Spot Size 1mm 950-1700 0.73 1.79
Spot Size 5mm 950-1700 0.94 0.86
  
Figure 5-6 The average of the concentrations predicted by PLS
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 regression. 
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Table 5-2 The standard error of concentration predicted by PLS regression. 
 
 
  
AsA Content
[%] Spot Size 1mm Spot Size 5mm
0 1.23 0.76
1 2.13 0.70
2 0.71 1.29
3 1.01 0.51
4 0.82 0.39
5 0.79 0.34
6 1.06 0.76
7 1.88 0.28
8 0.80 0.93
9 1.49 0.23
10 2.79 1.18
Average Standard Error[%]
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Figure 5-7  NIR images developed by the PLS models using data collected by the spot 
size 5 mm probe of 10% ascorbic acid. (A) NIR imaging of the AsA 10 
wt% tablet; sample 1, (B) NIR imaging of AsA 10 wt% tablet; sample 2, 
and (C) NIR imaging of AsA 10 wt% tablet; sample 3. 
 
 
 
 Figure 5
 
-8  The circle spot average AsA
imaging data of each sample was calculated and the difference from each 
circle spot average AsA concentration value with 5 mm spot average value 
as a reference plotted. 
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 concentration value of 1 - 9 mm of the NIR 
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Conclusion 
In this paper, the development of an inline NIR analyzer and portable NIR imaging 
device having high speed and high wavelength resolution characteristics were described 
and clarified the fact that these inline analyzers and NIR imaging devices are powerful 
tools for monitoring the pharmaceutical manufacturing process and for evaluating the 
quality analysis of pharmaceutical products.  
 
In Chapter 1, by realizing the real-time monitoring of the mixing process using an 
inline NIR analyzer featuring high speed and high wavelength resolution, equipped with 
high density and high sensitivity PDA detector developed, the usefulness of the NIR 
analyzer was demonstrated. In Chapter 2, using the developed NIR analyzer, the 
possibility of acquiring the tablet transmitted light was proved, an ultra-weak light, in 1 
second or less and showed the possibility of realizing the real-time release testing. In 
Chapters 3 and 4, by developing a portable NIR imaging device, these showed that the 
temporal change monitoring of the tablet dissolution process and the evaluation of the 
heterogeneity of mixed samples can be done in two dimensions and prompted the 
understanding of the physical properties of tablets and powders. In Chapter 5, in order 
to design the diffuse reflective probe of the inline NIR analyzer appropriately, a 
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switching system for the diffuse reflective probe and the NIR imaging device was 
developed, and showed the possibility of optimizing the spot size of the diffuse 
reflective probe to improve the accuracy of the quantitative analysis of the tablet.   
 
The researches have shown that the developed inline NIR analyzer and the portable 
NIR imaging device promote scientific understanding of the pharmaceutical 
manufacturing processes and formulations and in addition, they are tools for realizing 
adequate quality assurance. Further, the developed NIR analyzer and NIR imaging 
device have functions such as high speed, high sensitivity, high wavelength resolution, 
portability and so on that are useful for onsite analysis and hence their applicability to 
many applications is shown.  
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